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A. Executive Summary 
 
The purpose of this study was to identify and compare in broad terms laboratory capacity 
strengthening models in low and middle income countries (LMICs) focusing on enablers and barriers 
to success in relation to anti-microbial resistance (AMR) surveillance in different contexts. There is 
very little published information that focuses specifically on laboratory models for AMR surveillance. 
These models will require a combination of general approaches to strengthening the capacity of 
laboratories and their systems and networks, coupled with specific microbiological and other 
techniques needed for AMR. Due to the lack of AMR-specific information we sought information 
from electronic databases of publications from 1996-2016. This data was supplemented by 
interviews with key informants with relevant expertise including in AMR surveillance, microbiology 
and laboratory systems to provide in-depth information about the various types of AMR surveillance 
laboratory activities, outcomes and challenges, and sustainability issues. 
 
A data extraction matrix was used to capture the information necessary to analyse the various LMIC 
laboratory capacity strengthening models identified in the literature. Models were grouped 
according whether they were focused on individuals, institutions/laboratories and or the higher 
societal (i.e. national, regional and international) level. For individual staff the predominant model 
for enhancing their skills was training. This included through short courses focused on specific 
diseases such as malaria, or on generic skills such as tracking test accuracy. Repeated training in 
conjunction with regular supervision appeared to be effective at improving the skills of individual 
laboratory staff.  
 
The majority of programmes aimed improving the effectiveness of laboratories as institutions were 
focused on HIV or tuberculosis and were funded by external agencies. These programmes mostly 
aimed to achieve accreditation for the laboratory against international standards (generally, 
ISO15189 for clinical laboratories and ISO 17025 for veterinary laboratories).  
 
The types of topics covered which are all relevant for AMR surveillance included policies, laboratory 
management and planning, accreditation, quality systems and monitoring, laboratory capacity gaps, 
buildings, equipment, and human resource management and development. Successfully accredited 
laboratories had all appointed a quality officer or unit to guide and monitor the process of 
accreditation. The financial cost of an individual laboratory to achieve accreditation varied but was 
approximately £50,000 - £150,000. There are several resources available to support the accreditation 
process for clinical and veterinary laboratories including a stepwise improvement process which can 
help laboratories to monitor their graduated progress in implementing quality systems. 
  
Infrastructure upgrading was often a costly and time-consuming component of strengthening 
laboratory capacity especially for those needing high specifications such as biosafety level 3. The 
associated costs and complexity mean that only a few tertiary level facilities are able to achieve 
international accreditation and it is beyond the reach of most lower level laboratories where the bulk 
of the workload is incurred. The lack of accrediting bodies within many LMICs is also a barrier to 
timely accreditation and the increase in laboratories seeking accreditation has placed a strain on the 
few existing accrediting bodies in some regions such as South Africa.  
 
Despite the challenges to achieving accreditation, it has many benefits relevant for AMR surveillance. 
These include a decrease in wastage of laboratory reagents (1)which can contribute to offsetting the 
cost of accreditation, a reduction in complaints, increased demand for services, and improvements in 
pre-analytical, analytical and post analytical metrics. In contrast to the recent effort that has gone 
into achieving accreditation in LMIC laboratories, there is very little published evidence on how to 
sustain accreditation status logistically and financially and more work is needed to document the 
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logistics and costs and to balance this against the benefits, particularly in the context of AMR 
surveillance.    
 
For models that focused on ‘societal’ level – i.e.  the creation, consolidation or expansion, of 
national, regional or international laboratory networks – the following factors emerged as important: 
engagement with policymakers, assessments of laboratories participating in a network, upgrading of 
infrastructure, staff and systems, standardisation of methods, equipment and servicing, accreditation 
and regulation, and network coordination and communication. The WHO HIVResNet Drug Resistance 
Laboratory network provides an example that may be useful for AMR surveillance. This international 
network involves three tiers with the highest level supra-national laboratories setting standards, and 
providing a specialist testing service (e.g. genotyping) and technical assistance to other laboratories 
in the network which themselves are selected according to pre-defined criteria. 
 
Overall the models we have identified, which are mostly from disease-specific programmes, suggest 
that a combination of training, supervision, site visits and panel testing for laboratories will provide 
the best way of ensuring an effective AMR surveillance system. To achieve this, the laboratories need 
to train, retain and motivate skilled staff. Each laboratory should operate within a tiered laboratory 
network with clarity around reporting channels, and the roles and responsibilities of all those 
involved. Strong commitment by government is needed to establish and coordinate an effective AMR 
surveillance system across a country, to ensure appropriate linkages with international bodies and to 
coordinate activities of the private laboratories and external donors.  
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Fleming Fund: supporting surveillance capacity for antimicrobial resistance 
 
An analysis of approaches to laboratory capacity strengthening for drug resistant 
infections in low and middle income countries 
 
B. Introduction 
 
The purpose of this study was to identify and compare in broad terms laboratory capacity 
strengthening models in low and middle income countries (LMICs) focusing on enablers and barriers 
to success in relation to anti-microbial resistance surveillance in different contexts. This report covers 
six activities:  
 
1. Identify laboratory-strengthening models through a systematic review of the published and grey 
literature and through consultation with existing contacts in LMICs and relevant research and 
development organisations. 
 
2. Assess the strengths and weaknesses of each laboratory capacity strengthening model against a 
study-specific evaluation matrix. 
 
3. Produce a report comparing and contrasting each laboratory strengthening model according to 
the evaluation matrix, identifying contexts in which each model has been successful and 
presenting barriers and enablers present in different contexts. 
 
4. Identify different approaches for monitoring emergence and spread of resistance in different 
country settings, including the range of baseline data gathered. 
 
5. Assess the different approaches to monitoring resistance in each country and determine the best 
models and mechanisms for surveillance, capacity strengthening and training in the different 
country/regional settings. 
 
6. Produce a report documenting the different approaches for monitoring emergence and spread of 
resistance in each country and present the best models and mechanisms for surveillance, 
capacity strengthening and training in each. 
 
The short project duration necessitated a focus on broad, high-level data to provide an overview. We 
have supplemented this with more detailed data collection for selected countries and from 
individuals. Much of the information collected applies to general laboratory activities but is also 
relevant for surveillance systems. To provide more in-depth information about how different 
surveillance models operate in different contexts, we have conducted a comparison of antimicrobial 
surveillance systems based on site visits to three LMICs. These countries - Ghana, Nigeria and Nepal - 
were selected because they represented at least two different continents and included a ‘fragile’ 
state. (see separate LSTM CRU report 2016 ‘Supporting Surveillance Capacity for Antimicrobial 
Resistance: Regional Networks and Educational Resources’) 
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C. Methodology  
 
1. Literature Search 
 
1.1 Search strategy 
There are very few publications specifically focusing on anti-microbial resistance (AMR) surveillance 
laboratory activities, networks and systems. Publications with potential descriptions of, or references 
to, general laboratory capacity strengthening were therefore sought since these would also apply to 
AMR capacity and specific AMR-focused information was identified when available. Information was 
obtained from a search of the Medline, Web of Science, Global Health, PubMed, Google Scholar 
databases. The reference period for the search was January 1996 to June 2016. The search was 
limited to English language publications and was conducted using the following terms: laboratories, 
capacity strengthening, capacity building, scale up, accreditation, developing countries. Additional 
laboratory capacity strengthening publications were sought through a manual search of references 
listed in retrieved articles.  A standard Google search was also conducted to identify the web 
presence of laboratory capacity strengthening initiatives and any associated documentation.  
 
1.2 Model identification 
Retrieved publications, documents or reports were examined for references to laboratory capacity 
strengthening (including AMR-specific programmes) in low-middle income countries (LMIC) context. 
In the first instance, publication/document/report titles, abstracts and key words were reviewed 
against the following inclusion criteria: were within the reference period and had been implemented 
in an LMIC.  When all selection criteria were present, publications/documents/reports were kept for 
full text review or excluded if they did not meet all stipulated selection criteria. All laboratory 
capacity strengthening models identified during the course of the full text review that related to 
LMIC were recorded on a specifically designed excel spreadsheet. In addition, LSTM staff sent formal 
requests through their existing professional networks to identify relevant laboratory capacity 
strengthening initiatives. Key informants (described below) were also asked to identify relevant 
initiatives and documents. Any additional LMIC laboratory capacity strengthening models identified 
were added to the excel spreadsheet.  
 
1.3 Data extraction 
The research team developed and piloted a data extraction matrix designed to capture the 
information necessary to analyse each of the identified LMIC laboratory capacity strengthening 
models.  The components of the data extraction matrix focused on specific topics for analysis 
including the geographical and political context, methodology used, enablers and barriers, indicators 
for success and the evidence for these indicators being met.  Research team members reviewed all 
documents pertaining to each of the identified LMIC capacity strengthening models and mapped 
information onto the data extraction matrix.  
 
2. Key Informant Interviews 
 
Key informant interviews (KIIs) were conducted with purposively selected laboratory capacity 
strengthening experts from international agencies and practising senior laboratory staff (managers 
and scientists). Potential KIs were identified during the literature search, through existing 
professional networks and by other key informants (i.e. ‘snowball’ recruitment).  An introductory 
email was sent to all prospective KIs informing them about the study aims, requesting their 
participation and then inviting them to identify a date and time for possible interview.  Prospective 
KIIs who did not respond to the email invitation were subsequently contacted by telephone, 
informed about the study and invited to participate. All interviews were conducted by telephone and 
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Skype and followed a specifically-designed structured topic guide. The topic guide covered 
experiences and examples from their direct involvement in laboratory capacity strengthening 
programmes, types of activities, outcomes and challenges of the programme, and sustainability 
issues.  KIIs were audio recorded when possible and when permission was granted and detailed 
written notes taken.  The recordings were used to check the accuracy of the handwritten notes. KII 
data were entered on a study specific excel spreadsheet for subsequent analysis (further information 
is in annex 1). 
 
D. Findings 
 
This section presents an overview of the findings including the major types of laboratory capacity 
strengthening models relevant for AMR that we found in the literature and through our expert 
interviews. The type of studies identified and their geographical coverage is summarised in annex 2. 
Models were grouped according to the three levels of operation for capacity strengthening, 
individuals, institutions (i.e. laboratories) and societal (i.e. national, regional and international) (2). 
Capacity strengthening models at lower organisational levels were often used as part of larger 
models at higher levels. For example, training is present in the majority of models at all 
organisational levels. In some cases, elements of some models at societal level were required to 
support lower level models. For example, international external quality assurance (societal) is 
required for accreditation (organisational). 
 
1. Overview of laboratory capacity strengthening models presented in the literature.  
 
Thirty thousand four hundred and eighty papers (including duplicates) we found after searching all 
five databases. Five hundred and thirty-three papers were selected for abstract review and sixty 
papers were selected for data extraction.  
 
The methods used in the studies identified were either narrative, time series or ‘before and after’ the 
intervention, which means that the level of evidence was low or very low for the effectiveness of the 
models described. Many papers described the delivery of multiple components making the 
assessment of the relative effectiveness of each component difficult.   
 
2. Models focused on the individual level  
 
The predominant model for the capacity development of laboratory and related staff was training. 
Studies focused on individual level models are summarised in annex 3.  
 
Training 
Training of staff was often part of a larger capacity development model and will be discussed as part 
of those models. However, there were a number of papers that concentrated exclusively on 
delivering training. These are described below according to the type of training.  
 
Field Epidemiology and Laboratory Training Programmes 
Three papers looked at a specific programme, the Field Epidemiology and Laboratory Training 
Programme (FELTP). The first FELTP started in Kenya in 2003 as a 2-year regional public health 
leadership programme(3).  It initially covered Kenya, South Sudan, Ghana and Tanzania but has now 
expanded to cover 15 countries in sub-Saharan Africa. This has been achieved by franchising the 
course to institutions in other countries; there are now 10 FELTPs. The course focuses on four major 
scientific domains: epidemiology, public health surveillance, biostatistics and scientific 
communication.  Students undertake short and long term placements in public health.  
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The Nigerian FELTP was reviewed from 2008-14 (4) assessing numbers of students enrolled and their 
involvement in key public health activities (e.g. outbreak response, polio eradication and 
surveillance). The assessment also considered the number of papers presented at conferences and 
examples of grants awarded.  This was considered to demonstrate that course graduates were being 
used by the health system but the impact of this involvement was not specified. The cost of each 
FELTP was estimated at US$1-2 million comprising resident costs (e.g. research, books and tuition), 
programme costs (e.g. travel, supervision visits), technical support (CDC, Atlanta) and resident 
advisor salary (5).  
 
Short courses 
Two papers detailed short courses with specific outputs. On was an integrated management of 
malaria course (6) and one was to establish a system for monitoring the accuracy of results for 
commonly performed tests (7).  
 
For the malaria course laboratory staff were assessed on the quality of the malaria slide and the 
sensitivity and specificity of the blood smear result. Participants were followed up at 6 weeks, 12 
weeks and one year. All three indicators improved significantly at the first follow up and both 
sensitivity and specificity continued to improve up to one year. The evaluations were combined with 
support supervision visits which involved the reinforcement of training and helped to achieve the 
results.  
 
For the course for monitoring accuracy, supervisors trained laboratory staff over 18 months in 
common tests. During the last 6 months the accuracy of 11 tests were monitored which showed 
improvement in the accuracy of all tests.  
 
A third paper presented a web based training tool for improving the accuracy of 
immunohistochemistry. The study measured concordance between a US and Nigerian based 
institution after an initial exchange of samples. Web conferences were then held to discuss 
discrepancies between the two institutions. On a follow up exchange of samples concordance 
improved (8). A fourth paper looking at cytology training was purely a description of the course so it 
was not possible to assess an impact (9).  
 
From these examples repeated training courses delivered in conjunction with regular supervision 
appear to be effective at improving the skills of individual laboratory staff.  
 
3. Models focused on the institutional (i.e. laboratory) level  
 
Studies that focused on strengthening laboratories (i.e. institutional level) areas summarised in 
annex 3. The majority of laboratory capacity strengthening papers focused on the testing and 
management of HIV or tuberculosis with funding primarily from USA sources (CDC and PEPFAR). The 
main focus of laboratory strengthening for individual laboratories was for tertiary medical 
laboratories to obtain and sustain ISO15189 accreditation. The core elements covered by ISO15189 
are given in annex 4. For veterinary laboratories it was the related standard ISO 17025. Meeting the 
requirements set out in these standards means the laboratory has a functional Quality Management 
System (QMS) fit for use for medical/veterinary laboratories. QMS ensure that the services provided 
by an institution meet the requirements of the user. For diagnostic laboratories this focuses on 
accurate and timely results.  
 
Capacity strengthening at primary or secondary level focused on improving the physical 
infrastructure and training staff in specific testing methodologies and good laboratory practice (GLP) 
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and the establishment of quality assurance systems (QA) to monitor the quality of service. The 
establishment of QA systems is covered in section 4.  
 
Approaches to strengthening the capacity of laboratories used a combination of the following 
components: 
 
1. Inclusion of capacity strengthening of laboratories in policy documents 
2. Engagement of laboratory management 
3. Gap analysis of laboratories’ capacity 
4. Improvement planning 
5. Physical infrastructure upgrading (buildings and equipment)  
6. Human resource upgrading (training, restructuring) 
7. Developing quality management systems 
8. Monitoring quality (internal and external) 
9. Accreditation 
10. Sustaining accreditation 
 
The degree to which it was possible to implement these components depended in part on the size of 
the laboratory, managerial commitment, funding and external structures such as procurement and 
servicing. The details of each component are discussed in the following section. 
 
3.1 Laboratory capacity strengthening components 
 
3.1.1. Policy documents 
Many elements required for laboratories to become successfully accredited (e.g. procurement, hiring 
staff) are often beyond the control of the laboratory and cannot be achieved without higher-level 
support. A favourable policy environment where national laboratory strategic plans and guidelines 
for ISO15189 accreditation are endorsed and supported politically and financially were important for 
success (10, 11). However factors such as the decentralisation of services and the fragmentation of 
responsibility for laboratory services across multiple groups or government departments can block 
the implementation of these policies (12). The presence of a steering or advisory group for medical 
laboratories is useful to support the process of accreditation(13).  
 
3.1.2. Engagement of laboratory managers 
Accreditation requires alterations in the management structure and oversight from senior 
management as well as full commitment from the laboratory management team and higher-level 
institutional managers. Laboratories that sought ISO15189 accreditation independently generally 
achieved it quicker (1),(14) that those that were encouraged by external partners (15) indicating that 
management commitment is an important factor in driving accreditation.  
 
3.1.3. Gap analysis 
The majority of laboratories report undergoing a gap analysis using an external auditor either 
procured from a commercial supplier or provided by a donor funded programme (e.g. PEPFAR). 
Some accreditation projects used self-assessment checklists combined with support from external 
experts through activities such as workshops to help interpret the data generated. Evidence suggests 
that external input is important since unsupported use of the self-assessment checklist might lead to 
erroneous interpretations of compliance to the standard (16).  
 
A baseline gap analysis was seen as critical for enabling laboratories to prioritise and address gaps. 
Regular audits were generally used to assess progress. Most gap analyses focused on benchmarking 
current laboratory systems against quality standards such as ISO15189 or a national equivalent.  
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Njelesani et al (17) developed a set of tools for identifying strengths and gaps in neglected tropical 
disease (NTD) regional laboratory systems. The tools incorporated ISO15189 standards but expanded 
this toolkit to document the laboratories’ role in providing national and regional services to NTD 
control programmes (e.g. training and EQA) and participation in relevant networks and 
collaborations.  This toolkit was implemented in four LMIC NTD laboratories to support the 
development of collaborative, individualised capacity strengthening plans and to track progress.   
 
3.1.4. Improvement planning  
Laboratories that achieved accreditation formulated plans to prioritise activities to meet the 
requirements of the standard. These plans were regularly revised as activities were conducted and 
the systems and capacity improved.  
 
3.1.5. Physical infrastructure upgrading (buildings and equipment)  
This component covers the construction and refurbishment of laboratory buildings at all levels of the 
health system. Improvements were made to accommodate new testing (e.g. molecular), stabilise 
utilities (i.e. electricity, water, communication), improve safety for staff and the public (e.g. signage 
and restricted access), environmental control (i.e. temperature and humidity), and to increase and 
modify space (e.g. to accommodate increased testing, specimen and record archiving, improve 
workflow and provide training).  
 
This component includes equipping of laboratories to allow new or improved testing (e.g. automated 
blood culture), improved safety (e.g. fire extinguishers, autoclave) and security, introduced or 
expanded specimen and reagent storage (e.g. refrigerators and freezers), data transmission and 
storage (e.g. computers) and stabilised power supply (e.g. generator).  
 
This infrastructure upgrading was often a very costly and time-consuming element of the process of 
capacity strengthening especially for laboratories needing a high specification, such as biosafety level 
3 (18).  
 
3.1.6. Human resource upgrading (training, restructuring) 
Successfully accredited laboratories had all appointed a quality officer or unit to guide and monitor 
the process of accreditation. A full time quality manager was seen as important to drive the 
development of a QMS (11).  This position is required by ISO15189 to be independent of the 
laboratory management structure, reporting directly to the head of the laboratory.  ISO15189 also 
requires the establishment of other positions, such as a biosafety officer, all of which require 
significant investment in staff time and training.  
 
A lack of detailed knowledge amongst laboratory staff and management around quality issues was 
commonly observed. Regular training for all staff was seen as important in establishing and 
maintaining a culture of quality within the laboratory (1), (19) . In some cases an external advisory 
group was formed to guide and monitor progress (1). The WHO in collaboration with other partners 
has developed tools to support training in QMS (see section 3.5).  
  
3.1.7. Developing and monitoring quality management systems 
Once staff have received training and the management structure for QMS has been established, 
laboratories were able to put in place systems for monitoring and improving quality. Implementation 
was generally a stepwise process based on ‘plan, do, act, and check’ cycles characteristic of 
improvement planning (Section 3.1.4). Tools are available to support this process and examples are 
given in Section 3.5. Continuous benchmarking and formal documentation of progress against 
international standards could be a motivating factor for maintaining laboratories’ commitment to 
progress to accreditation(11). Enrolment in international proficiency testing is a requirement of 
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ISO15189. International schemes can be expensive so some countries, such as Thailand, India, 
Jordan, Pakistan and the Caribbean region have established their own schemes (11, 16, 20-22).  
 
3.1.8. Accreditation 
 
3.1.8.1 Clinical Laboratories  
ISO15189 was the most common standard used by laboratories seeking accreditation (23). Countries 
such as Thailand, India and Argentina have developed and introduced their own national standards 
based on ISO15189 (21). However, in Thailand only 80% of the standard’s requirements have to be 
met to achieve accreditation, whereas for ISO15189 all have to be met. There were examples of both 
internally and externally initiated (e.g. donor) decisions to become accredited. Data from the 
literature indicated that accreditation took between 2-10 years with externally initiated processes 
taking longer. The lack of accrediting bodies within many LMICs is a barrier to timely accreditation.  
The increase in laboratories seeking accreditation has placed a strain on the accrediting bodies in 
some regions (e.g. South African National Accreditation System) and sourcing accreditation visits out 
of country also increases costs.  
 
Other accreditation systems also exist such as the WHO accreditation scheme for polio laboratories 
and good clinical laboratory practice. Though the specifics of the standards vary they all have the 
same underlying principle of establishing a functional laboratory QMS.  
 
3.1.8.2 Veterinary  
 Veterinary laboratories use the World Organisation for animal health (OIE)1 standard (based on ISO 
17025:2005) for accreditation but we could not find any published accounts of laboratories working 
towards this standard in LMIC. The OIE operates a twinning programme between its reference 
laboratories and LMIC partner laboratories. These projects address specific diseases but also broader 
issues such as improving diagnostic capacity.  All projects are required to advance the partner 
laboratories to meet OIE standards. Currently LMIC with OIE accredited reference laboratories are: 
South Africa, Mexico, Argentina, Cuba, Thailand, Botswana, Senegal, Russia, Morocco, China, Brazil, 
India, Chile, Panama, Iran, Hungary.  
 
3.2 Challenges in achieving and maintaining accreditation 
In this section we present the challenges to achieving and maintaining accreditation present in the 
literature and raised by key informants. There is very little published evidence on how to sustain 
accreditation. The majority of published literature focuses on how laboratories can achieve 
accreditation, though as more laboratories become accredited more evidence may become available. 
Laboratories that did report on sustaining accreditation were private or donor funded (1), (14).   
 
3.2.1 Adequate skilled staff 
The process of accreditation is very labour intensive requiring the involvement of many staff in the 
development of documentation and increasing their time spent on recording requirements and other 
procedures. This, and the stringent infrastructure requirements, is partly the reason that ISO15189 
accreditation has so far been limited to well-staffed tertiary level laboratories in LMICs.  
 
The training given to laboratory staff to equip them to support accreditation also means they are 
highly attractive to other laboratories within the same sector and makes retention of these staff 
difficult (1). Skilled laboratory staff in many LMICs are in demand and there often exists a national 
market where both the private and non-governmental sector compete with the public sector for a 
                                                        
1 
http://www.oie.int/fileadmin/Home/eng/Support_to_OIE_Members/docs/pdf/projects_completed_underway
.pdf 
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small pool of staff (24).  This movement of staff has been responsible for some laboratories being 
unable to maintain progress (25). However, if they can be retained, these staff are a valuable asset 
for maintaining accreditation. Performance-based financial incentives have been raised as a possible 
way to retain staff (26) 
 
3.2.2 Equipment maintenance/servicing 
Equipment maintenance is often highlighted as a barrier to achieving accreditation. Many countries 
lack in-country expertise required to service laboratory equipment and have to source expertise 
internationally which is expensive and can lead to delays in servicing(27). A recent survey of eight 
microbiology laboratories in Kenya, including two reference level facilities, indicated that none of 
them had services contracts in place(28). 
 
Better training and retention of biomedical engineers in LMICs has been raised as a potential solution 
to this issue.(29) Three papers specifically focus on the training of biomedical engineers.  Abimiku 
(30) et al describe centralised training of biomedical engineers to support the PEPFAR funded 
ACTION programme in Nigeria which supports HIV diagnosis and management. This periodic training 
was done in collaboration with manufacturers. No results on the impact of this on equipment 
function were presented.  
 
Hamel et al (31)describe the training of biomedical engineers in Nigeria to support HIV diagnosis and 
care.  In this intervention on-site engineers were trained and provided periodic scheduled 
maintenance of equipment. The engineers received additional specialist equipment training out of 
country.  The programme was reported to reduce equipment downtime and manufacturer service 
call outs, and increased the timely use of test reagents.  
 
Makin and Keane analysed equipment repair requests from 60 hospitals in 11 LMIC where US trained 
biomedical engineer volunteers had been placed(32). These volunteers were able to put 72% of 
equipment back into service without imported spare parts. 99% of repairs were covered by 6 
domains of knowledge (electrical, mechanical, plumbing, installation/training, power supply and 
motors). They found that only 107 skills would be required to get 66% of equipment back into service 
without the use of imported spare parts and presented a simplified training curriculum. Though this 
programme was not focused on laboratories, many items of equipment critical to an AMR laboratory 
were listed (e.g. microscopes, incubators, autoclaves). Investment in biomedical engineering capacity 
would have a wider impact on hospital services in addition to AMR and reduce costs associated with 
equipment malfunctions. However there is a risk of high turnover of trained staff highlighted by 
Abimiku et al(30). 
 
3.2.3. Procurement systems 
The majority of laboratories in the public sector in LMICs do not have control over procurement. For 
those that do, a lack of in-country suppliers for specialist equipment and stringent and complex 
procurement regulations can result in very long lead times (1, 11).  It is recommended that this be 
assessed as part of any initial capacity gap analysis (15).  
 
3.2.4 Funding 
Laboratories that have achieved accreditation have either been private or donor funded laboratories. 
For the laboratory accreditation process to be successful it is important that the total cost of 
achieving accreditation is guaranteed up front. The large variability in time and resources required 
for laboratories to achieve accreditation makes securing these funds difficult. Also without direct 
budgetary control, the efficiency savings gained by implementing a QMS may not be properly 
documented or passed onto the laboratory.  
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3.3 Impact 
A number of impacts from laboratory accreditation are described in the literature and these are 
summarised below. 
 
3.3.1. Reduction of wastage 
Accredited laboratories report a decrease in wastage of laboratory materials such as reagents (1) 
that can contribute to, or entirely offset, the cost of accreditation (14).  
 
3.3.2. Reduction in complaints 
The improvements in reporting times and the reliability and accuracy of results has been attributed 
to a reduction in complaints. In Kenya, a reduction of 82% in the number of complaints was observed 
in the first 12 months after accreditation in Kisumu (1) and a similar reduction occurred at the Aga 
Khan hospital (14). 
 
3.3.3. Improvement in pre-analytical, analytical and post analytical metrics.  
Laboratories report significant improvements in these metrics (1), (14), (33). This is unsurprising as 
the purpose of a QMS is to monitor and improve these metrics.  
 
3.3.4. Increase in demand for services 
Laboratories report an increase in demand for services due to a perceived improvement in the 
quality of service(1) .  
 
3.3.6 Improved human resources 
As well as the generation of a highly skilled workforce in the laboratory, accreditation was noted to 
have fostered a better relationship between the laboratory and clinicians(14). This was thought to be 
due to the emphasis in the accreditation process on establishing clear communication with clients.  
 
3.4 Costs associated with laboratory accreditation 
Costs obtained from the literature are detailed below. All costs are adjusted for inflation2. 
 
3.4.1 Costs for accreditation 
 
Component Source and cost (USD) 
Zeh et al (1) 
Kenya 
Kibet et al (14) 
Kenya 
Opio et al (13) 
Uganda 
 
Gap analysis  69,519 -   
Training   35,223 -   
EQA  16,372 -   
Accreditation   19,070 -   
LMIS  5,793 -   
Temperature 
monitoring 
system 
758 -   
Total  146, 630 96,120 57,932 – 115,865  
 
 
  
                                                        
2 CPI Inflation Calculator http://www.bls.gov/data/inflation_calculator.htm 
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3.4.2 Costs of sustaining accreditation 
 
Component Source and cost (USD) per year 
Zeh et al (1) 
Kenya 
Kibet et al (14) 
Kenya 
Elbireer et al (34) 
Uganda 
Training   15,293 -   2,591 
LMIS  5,793    3,872 
Preventative maintenance     49,116 
Office supply costs     608 
Personnel time    97,077 
EQA  24,558 -   23,469 
QA reagents     391,374 
Process improvement activities     7,348 
Internal/external comparison 
testing 
    1,180 
Accreditation  35,478 -   17,380 
Temperature monitoring system  1,307 - - 
Total 82,430  32,040  594,098 
 
The lower cost of accreditation experienced by Kibet et al (14) was attributed to the availability of 
local QMS training where as Zeh et al (1) had to source training from outside the country.  The costs 
in the Elbireer et al (34) study were seven times higher than Zeh et al (1), representing 32% of total 
laboratory expenditure, because they included many more components.  
 
Kibet et al (14) stated that improved efficiency offset the cost of maintaining accreditation and 
estimated the cost savings to be $42,000 similar to the figure of $37,000 estimated by Elbireer et al 
(34). It is important to note that both of these laboratories required minimal physical infrastructure 
upgrades which could be a significant proportion of the costs for laboratories with less modern 
infrastructure.  
 
3.4.3 Infrastructure, human resource and reagent costs 
 
Laboratory Type and 
Infrastructure 
Component 
Source and cost (USD) 
Herva et al 
(1999)(35) 
Philippines 
Paglia et al 
(2012) 
Tanzania 
Paramasivan et 
al (18)* 
Lesotho 
Dacombe et al 
(36)* 
Malawi 
Laboratory type Microbiology TB BSL-3 BSL-3 
Equipment   24,025  7,647  75,321  88,966 
Building improvement  - -  107,754  148,039 
Technical Assistance  26,010/year  -   55,331 
Reagent costs/year  19,495   324,421  
Human resource/year  40,828   104,778  
 
* These studies look at the costs of setting up Bio-Safety Level 3 laboratories that have a high 
specification and construction costs.  
  
3.5 Available tools and support for accreditation 
The Stepwise Laboratory Improvement Process Towards Accreditation (SLIPTA) tool was developed 
in 2009 by the World Health Organisation (WHO) to help laboratories to progress towards ISO15189 
standard (19, 37).  It is essentially a checklist to score compliance with ISO15189 using a five-star 
system, with five stars indicating the laboratory is ready for assessment by an accrediting body 
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(annex 5). The African Society of Laboratory Medicine is supporting a cadre of assessors to visit 
laboratories and certify their progress through the SLIPTA five-star system. A similar process is in 
place for blood transfusion services organised by the African Society for Blood Transfusion.  
 
SLIPTA is supplemented by the Strengthening Laboratory Management Toward Accreditation 
(SLMTA) training model. It is directly linked to the SLIPTA audit process and provides educational 
material on QMS to help accelerate progress towards ISO15189(38-40).  In 2014 the WHO launched 
an online tool, Laboratory Quality Stepwise Implementation (LQSI) tool to support laboratories 
aiming to attain ISO15189 accreditation (41). These tools have been extensively used in both sub 
Saharan Africa and the Caribbean. Some laboratories have also used the six sigma metrics for 
monitoring progress (14). 
 
The OIE have developed a Performance of Veterinary Services (PVS) pathway for improving 
veterinary services that includes laboratory components (42) and is similar to the SLIPTA model. The 
pathway starts with the OIE conducting evaluations of countries veterinary services including 
laboratory components at the request of individual countries.  This is followed by a gap analysis to 
identify and set priories for the veterinary programme. Specific activities are then undertaken to 
address these priority gaps3. This cycle is then repeated starting with another evaluation visit. 
 
Twinning 
There are a few examples of twinning of LMIC laboratories with a high-income institution. For 
example support was provided for 2 years to microbiology laboratories in the Philippines through the 
provision of equipment, reagents and ongoing equipment monitoring, EQA and technical 
expertise(35). This intervention resulted in a large increase in the number of samples processed and 
improvement in concordance in species identification.  
 
3.6 Limitations of the laboratory accreditation process 
ISO15189 is a very good framework to improve the functioning of laboratories in terms of monitoring 
and improving the entire testing process from sample collection, testing, reporting and disposal. 
However even with intensive support and good leadership, achieving accreditation takes several 
years. It is also costly to undertake both in cash terms and in staff time limiting its practical 
application to large relatively well-funded facilities. It can also be costly to maintain, though the costs 
of this may be offset by efficiency savings through improvements in procurement and use of 
resources.  
 
The implementation of the SLIPTA stepwise model partially offsets these problems but raises its own 
issues. Certification by SLIPTA assessors of the stage reached by a laboratory does demonstrate 
progress by a laboratory towards the ISO15189 standard. However it is not in itself a demonstration 
of a functional QMS as the score only reflects the number of requirements met and not if those 
requirements function together to improve quality. The same argument can be levelled at other 
accreditation programmes, such as the national scheme in Thailand, which only requires 80% of the 
ISO15189 requirements to be met. The LQSI tool does group requirements into four logical stages 
but its impact on laboratory quality remains to be investigated.  
 
Since these models focus on the implementation and maintenance of a QMS, they do not directly 
address broader issues that are important for capacity strengthening such the relationship and role 
of the laboratories with their host institutions, regional collaborations and networks, and strategic 
planning to expand services and sustain funding (43). 
 
                                                        
3 http://www.oie.int/doc/ged/D14095.PDF 
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4 Models focused on societal (i.e. national, regional and international) level laboratory strengthening  
 
Societal capacity strengthening for laboratories can be conceptualised as the creation of national, 
regional or international networks. However, the activities carried out at each level are similar. 
Generally, the bigger the scope of the network, the less in-depth the activities to support it can be 
due to increasing cost.  
 
The activities required to build and support a laboratory network that have been presented in the 
literature (which is summarised in annex 3) are: 
 
1. Engagement with policymakers 
2. Gap analysis of laboratories intending to join the network 
3. Upgrading of laboratory infrastructure, human resources and quality management systems  
4. Standardization of laboratory methods, equipment and servicing across the network 
5. Accreditation and regulation 
6. Network coordination and communication 
 
Since the Maputo declaration in 2008, national laboratory networks in LMICs have been developed in 
line with the establishment or strengthening of a tiered laboratory network (44). A national tiered 
network consists of four levels: 
 
National Tiered Laboratory Network 
 
Level Laboratory Type Example 
4 National Reference HIV reference laboratory 
3 Regional/Provincial  Tuberculosis microscopy QA 
laboratory 
2 District District hospital  
1 Primary Health post/centre 
 -  
The Level 4 laboratories should be linked to regional or international level laboratories for the 
purpose of quality assurance, specimen referral and technical assistance. For example, 
internationally quality assurance of tuberculosis testing is managed through a network of supra-
national reference laboratories that act as regional reference centres.  
 
Many disease-specific programmes have established international tiered laboratory networks for 
example for rotavirus (45), HIV (46), polio (47), measles and rubella (48), and  tuberculosis (49).  The 
WHO HIVResNet Drug Resistance Laboratory network provides a typical example. This network 
operates a three tier international structure. Specialised drug resistance laboratories set standards 
for the network and provide technical assistance to other laboratories in the network.  Regional drug 
resistance laboratories function as reference centres for countries that do not have a national drug 
resistance laboratory and provide training and technical assistance to national drug resistance 
laboratories within their region. National drug resistance laboratories provide specialist-testing 
service (in this case genotyping services) on nationally collected survey samples. All these 
laboratories are selected based on pre-defined criteria established by WHO (50). This structure is 
generally replicated in other international disease control networks.  
 
4.1. Engagement with policymakers 
Many studies cited the engagement of local health and government officials as important for the 
efficiency and success of their laboratory networks(51). Joint planning has often been used as an 
approach to ensure coordination between the development of networks and the countries involved 
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(52). The development of laboratory strategic plans with clear goals and activities has been 
promoted by international organisations such as WHO.  Strong relationships with the national 
ministry of health is important to mitigate possible threats to the network such as the redeployment 
of skilled staff. Insufficient political commitment and lack of skilled human resources were raised by 
the majority of interviewees as major challenges facing laboratory capacity strengthening efforts.  
 
4.2 ‘Gap analysis’ assessments of laboratories within a network 
Questionnaires are often used to analyse capacity gaps of large numbers of laboratories in a network 
(33), such as large multi-country networks, and are generally sent to a contact person within the 
laboratory to complete (17, 53). In one study in Thailand a QMS self-assessment was evaluated with 
follow up visits by the national accreditation body(16). This showed significant differences between 
the self-assessment and the accreditation visit indicating that the self-assessment approach may not 
be an accurate way of assessing the functionality of laboratory systems.  
 
For networks involving smaller numbers of laboratories, site visits similar to the assessments used for 
institutional capacity have been conducted using tools such as checklists (28, 30, 52). Although time 
constraints mean these are often less detailed than the ones used for accreditation assessment they 
can be used for monitoring and evaluating laboratories in a network over time.  
 
4.3. Upgrading of quality management systems, laboratory infrastructure and human resources 
 
4.3.1 Establishing EQA systems 
EQA is critical for a laboratory to be able to monitor and demonstrate the accuracy of its testing. 
Three types of EQA systems were identified from the literature and are summarised below.  
 
Panel testing 
Nine papers describe the setting up and/or operation of EQA programmes that involve a central 
laboratory sending samples to recipient laboratories which they test using their routine procedures 
(panel testing)(45, 48, 54-60). The laboratories send the results to the central laboratory which 
compares laboratories’ results with the true results. Many EQA programmes look for concordance 
among participating laboratories to check the accuracy of the central laboratory’s own results. 
Feedback is sent to participating laboratories about their performance but in some schemes, there 
may be significant delays. Since these systems can only detect errors but not the cause, laboratories 
that do not perform well are expected to have mechanisms in place to identify problems and take 
remedial action. 
 
When EQA panel testing has been implemented as a stand-alone intervention without any 
supervision or remedial processes, it has not been shown to improve performance. However, panel 
testing can be scaled up relatively easily making it ideal for EQA programmes requiring an 
international scope. When combined with other interventions such as on-site supervision and repeat 
training it is an important way to achieve and monitor changes in performance of an individual 
laboratory and a laboratory network and could be applied in the context of AMR surveillance. The 
cost for the 2016-7 enrolment in the NEQAS AMR EQA is £402. 
 
Blinded rechecking  
Another model of EQA presented is the blinded rechecking of sample results by a second (normally 
higher tier) laboratory.  This is most commonly used for slide based diagnosis (e.g. tuberculosis and 
malaria) but has also been applied to antimicrobial susceptibility testing (AST).  Blinded rechecking 
can provide feedback to laboratories but like panel testing, time delays may be significant. Feedback 
will be non-specific as only the error can be detected in these systems not the root cause.  
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Supervision 
Supervision of testing sites involves periodic assessment visits to each site by supervisors and has 
been used extensively in HIV, malaria and tuberculosis programmes(61-64). It is used in international 
networks such as the global rotavirus surveillance network (45). Supervisory visits enable the entire 
QMS of the laboratory to be assessed (generally using a standardised checklist) and has the potential 
to give rapid feedback to specifically address any root causes of errors that have been detected. 
Results of blinded rechecking of tuberculosis smear microscopy centres receiving on site supervision 
have shown an increase in laboratories with no errors detected.  An HIV programme in Nigeria 
showed a significant reduction in sites registering non-conformities after the introduction of 
supervision combined with training and renovation (30).  A HIV study involving laboratory 
supervision in 5 LMICs also demonstrated a similar reduction in errors over a four-year period (65). 
This suggests that on-site supervision does have a positive effect on testing quality. However due to 
the transport and personnel costs routine supervision may be expensive to operate and therefore 
can be difficult to sustain. 
 
4.3.2 Training of staff 
Training of staff across a network of laboratories has been achieved using a number of different 
approaches alone or in combination(26, 66). These have included self-training using e-resources (67), 
on-site training (68) (26, 69, 70), centralised in-country training (26, 60, 66) and out-of-country 
training (65, 66, 69, 70). For technical and QMS training(30) the most common combination was 
centralised training followed by on-site training often combined with supervision visits.  On-site 
training was preferred, as it did not take staff away from their workplaces.  
 
In conflict zones centralised training has the advantage of providing training in a secure environment 
(66) with less risk to trainers though for participants, travel in conflict zones may pose additional 
hazards.  Centralised training can also provide introductory technical training on a new technology 
platform before it is rolled out(51). However, delays in roll out may reduce the effectiveness of this 
training since new skills will be lost quickly if there is no opportunity to use them in practice. 
Centralised training can also be structured to allow the sharing of experiences between groups in 
different locations. (31, 69) 
 
Large country programmes have established in-country training centres housed at tertiary level 
facilities (26, 30) and trained a cohort of in-country trainers (‘training of trainers’) who are able to 
conduct on-site training (26), (66). Large regional training centres can also provide specialist 
laboratory training. For example, the African Centre for Integrated Laboratory Training, South Africa 
(26) focuses on technical training for tuberculosis and HIV but also provides general courses on QMS, 
biosafety and strategic planning. The application process involves in-country CDC laboratory 
directors.  
 
4.3.3 Laboratory Infrastructure 
Most national laboratory strengthening programmes involved some upgrading of physical laboratory 
infrastructure (29-31, 51, 65, 66). Many found the process time consuming and costly. Example costs 
of laboratory renovations are given in section 3.4. In Peru the upgrading of the tuberculosis network 
infrastructure was delayed by around 6 months due to government requirements (29).  A trial in 5 
LMICs reported that it took 2 years to renovate laboratories (65).  In Peru local experts were trained 
in the design of laboratories to sustain the expansion of the network.  
 
4.3.4. Standardization of laboratory methods, reporting, equipment and servicing across networks 
 
4.3.4.1 Standardization of methods 
Many networks develop standard operating procedures (SOPs) for common processes across the 
network such as testing and sample referral(45, 65).  These are often produced by the networks’ high 
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level reference centres giving the advantage that the SOPs will be in-line with the latest knowledge. 
This also reduces the workload on less well staffed national and sub-national laboratories and allows 
for standardisation of training and reporting(51). Standardization of reporting is critical to ensure 
that the data the network generates can be validated and analysed. Many networks have introduced 
common electronic laboratory management information systems to address this (52, 67) and to help 
monitor QA (65). Staff training and routine validation processes are important components of these 
information systems.   
 
4.3.4.2 Integration of laboratory activities across vertical disease programmes 
Integration has been discussed as an opportunity to build on disease-specific investment in 
laboratory services, particularly in relation to HIV (26), for the benefit of other diseases.  The 
expansion of activities which were initially set up as part of  disease-specific programmes, such as on-
site supervision, specimen transport, EQA and accreditation programmes, and staff training to 
incorporate other diseases is likely to be cost effective (71).  
 
A study in Nigeria proposed a model for assessing integration (72). They split integration into two 
domains, physical/structural and virtual/service and presented specific components to be assessed 
under each domain. They carried out a series of interventions in 122 facilities mainly focused on the 
virtual/service domain which included establishing a common management structure, training and 
mentorship of all laboratory staff and encouragement of regular staff rotation, making all equipment 
generally accessible and serviced, nomination of a quality manager to oversee all areas of the 
laboratory and distribution of an electronic laboratory management information system to all 
sections of the laboratory. These interventions were assessed after 3 months and the proportion of 
laboratories demonstrating some service integration rose from 53% to 82%.  Although other impacts 
of this integration were not assessed it does present a framework to evaluate the process of 
integration in countries where there have been significant disease-specific investments in 
laboratories.  
 
4.3.4.3. Standardization of equipment and servicing   
A number of programmes have found the use of non-standard equipment a challenge(51, 64).  
Heterogeneous equipment makes it difficult to standardise methods and reagents and can therefore 
increase the cost and complexity of procurement. Procurement regulations which are put in place to 
ensure fair tendering and uncontrolled donation of equipment, can act as barriers to equipment 
standardisation. Strong governmental leadership and commitment is required to overcome these 
barriers because they need to be guided by a national strategy (73).  
 
4.3.5. Accreditation/regulation 
For reference level laboratories in a laboratory network, accreditation is desirable and often 
required. The costs involved put such accreditation schemes beyond the reach of lower level 
laboratories in LMICs which are often better served by well-supported QA systems, possibly 
managed by the reference laboratories, and monitored by regular on-site visits. The SLIMTA process 
offers a way to encourage laboratories to progress towards accreditation but the scoring system is 
not necessarily indicative of a functional QMS.  
 
Many WHO disease specific programme networks accredit laboratories using their own criteria. For 
example, the Global Measles and Rubella Laboratory Network uses seven performance criteria 
focusing on the timeliness of results, EQA panel test and rechecking concordance and 
implementation of a specified quality control procedure(48). At national level, peer networks for the 
development of QMS and educational visits to accredited laboratories for staff involved in 
developing QMS have been shown to be helpful (16). More countries need to be supported to 
develop their own regulatory systems for laboratories both to promote ownership and to release the 
pressure on existing accrediting bodies such as those in South Africa.  
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4.3.6 Network coordination  
Regular communication through virtual and physical meetings has been raised as important for the 
functioning of a laboratory network. The Global Measles and Rubella Laboratory Network facilitate 
communication through regional laboratory coordination meetings every 1-3 years. Each region also 
has a dedicated laboratory coordinator whose role is to work with ministries of health to support and 
expand the network (48).   
 
4.4 Challenges  
The following challenges were identified through interviews and from the literature. 
 
 The difficulty in securing political commitment and long term funding was a concern for ensuring 
the sustainability of laboratory strengthening projects. This is a particular problem when 
programmes are supported by external donors with time-limited funding since the cyclical and 
relatively short nature of grants does not fit with the long term commitment required to 
strengthen laboratories.  
 
 In determining the direction and activities for strengthening laboratory capacity, there may be 
tensions between the nation’s needs and donors’ agendas. The focus should be on tests of public 
health importance and take account of clinicians’ requirements. 
 
 Insufficient numbers of suitably trained, qualified and motivated laboratory staff in LMICs was 
considered a major and common challenge.  Better career pathways for laboratory staff and for 
encouraging women into senior laboratory positions may help to mitigate this problem.  
 
 The cost of sending samples for EQA programmes is often very high and international regulations 
can be difficult to navigate(74). Some networks have tried to reduce shipment costs for example 
by using dried blood spots, which are exempt from dangerous goods regulations(48) 
 
 In some LMICs private laboratories play an important role but their integration into disease 
surveillance and quality assurance networks has proved difficult. Their inclusion in confirmatory 
testing schemes has met with some success (48) 
 
 The majority of service delivery is done by laboratories in the lower tiers but they are least able 
to access reagents, equipment maintenance and quality assurance schemes. It is therefore 
important for national surveillance and case management that they are incorporated into strong 
national quality, procurement, training, supervision and monitoring systems  
 
 More systematic and robust ways of measuring the impact of laboratory strengthening efforts 
are needed to be able to better understand which approaches are most effective and in which 
contexts.  
20 
 
References 
 
1. Zeh CE, Inzaule SC, Magero VO, Thomas TK, Laserson KF, Hart CE, et al. Field experience in 
implementing ISO 15189 in Kisumu, Kenya. Am J Clin Pathol. 2010;134(3):410-8. 
2. Bates I, Boyd A, Smith H, Cole DC. A practical and systematic approach to organisational capacity 
strengthening for research in the health sector in Africa. Health Res Policy Sy. 2014;12. 
3. Mosha F, Oundo J, Mukanga D, Njenga K, Nsubuga P. Public health laboratory systems 
development in East Africa through training in laboratory management and field epidemiology. 
Pan Afr Med J. 2011;10 Supp 1:14. 
4. Nguku P, Oyemakinde A, Sabitu K, Olayinka A, Ajayi I, Fawole O, et al. Training and service in 
public health, Nigeria Field Epidemiology and Laboratory Training, 2008 - 2014. Pan Afr Med J. 
2014;18 Suppl 1:2. 
5. Nsubuga P, Johnson K, Tetteh C, Oundo J, Weathers A, Vaughan J, et al. Field Epidemiology and 
Laboratory Training Programs in sub-Saharan Africa from 2004 to 2010: need, the process, and 
prospects. Pan Afr Med J. 2011;10:24. 
6. Namagembe A, Ssekabira U, Weaver MR, Blum N, Burnett S, Dorsey G, et al. Improved clinical 
and laboratory skills after team-based, malaria case management training of health care 
professionals in Uganda. Malar J. 2012;11:44. 
7. Bates I, Bekoe V, Asamoa-Adu A. Improving the accuracy of malaria-related laboratory tests in 
Ghana. Malar J. 2004;3:38. 
8. Oluwasola AO, Malaka D, Khramtsov AI, Ikpatt OF, Odetunde A, Adeyanju OO, et al. Use of Web-
based training for quality improvement between a field immunohistochemistry laboratory in 
Nigeria and its United States-based partner institution. Ann Diagn Pathol. 2013;17(6):526-30. 
9. Field AS, Geddie W, Zarka M, Sayed S, Kalebi A, Wright CA, et al. Assisting cytopathology training 
in medically under-resourced countries: defining the problems and establishing solutions. Diagn 
Cytopathol. 2012;40(3):273-81. 
10. Nkengasong JN, Mesele T, Orloff S, Kebede Y, Fonjungo PN, Timperi R, et al. Critical role of 
developing national strategic plans as a guide to strengthen laboratory health systems in 
resource-poor settings. Am J Clin Pathol. 2009;131(6):852-7. 
11. Alemnji GA, Branch S, Best A, Kalou M, Parekh B, Waruiru W, et al. Strengthening national 
laboratory health systems in the Caribbean Region. Glob Public Health. 2012;7(6):648-60. 
12. Olmsted SS, Moore M, Meili RC, Duber HC, Wasserman J, Sama P, et al. Strengthening 
laboratory systems in resource-limited settings. Am J Clin Pathol. 2010;134(3):374-80. 
13. Opio A, Wafula W, Amone J, Kajumbula H, Nkengasong JN. Country leadership and policy are 
critical factors for implementing laboratory accreditation in developing countries: a study on 
Uganda. Am J Clin Pathol. 2010;134(3):381-7. 
14. Kibet E, Moloo Z, Ojwang PJ, Sayed S, Mbuthia A, Adam RD. Measurement of improvement 
achieved by participation in international laboratory accreditation in sub-Saharan Africa: the Aga 
Khan University Hospital Nairobi experience. Am J Clin Pathol. 2014;141(2):188-95. 
15. Anisimova VD, TAM; Engelberts, MF; Kachuwaire, O; Oskam, L; Scholten, J. ISO 15189 Quality 
Management System Implementation: Look Before You Leap. 2015. 
16. Kanitvittaya S, Suksai U, Suksripanich O, Pobkeeree V. Laboratory quality improvement in 
Thailand's northernmost provinces. Int J Health Care Qual Assur. 2010;23(1):22-34. 
17. Namatovu A, Wekesa SN, Tjornehoj K, Dhikusooka MT, Muwanika VB, Siegsmund HR, et al. 
Laboratory capacity for diagnosis of foot-and-mouth disease in Eastern Africa: implications for 
the progressive control pathway. BMC Vet Res. 2013;9:19. 
18. Paramasivan CN, Lee E, Kao K, Mareka M, Kubendiran G, Kumar TA, et al. Experience 
establishing tuberculosis laboratory capacity in a developing country setting. Int J Tuberc Lung 
Dis. 2010;14(1):59-64. 
19. Gershy-Damet GM, Rotz P, Cross D, Belabbes el H, Cham F, Ndihokubwayo JB, et al. The World 
Health Organization African region laboratory accreditation process: improving the quality of 
laboratory systems in the African region. Am J Clin Pathol. 2010;134(3):393-400. 
21 
 
20. Ahmad M, Khan FA, Ahmad SA. Standardization of pathology laboratories in Pakistan: problems 
and prospects. Clin Biochem. 2009;42(4-5):259-62. 
21. Sachdeva KS, Nagaraja SB, Kumar A, Kumar P, Ramachandran R. Certification of TB culture and 
drug susceptibility testing laboratories through the Revised National Tuberculosis Control 
Programme (RNTCP). J Indian Med Assoc. 2012;110(7):488-9. 
22. Bilto YY. Consensus and accuracy in haematology laboratories of developing countries: the 
Jordanian experience. Clin Lab Haematol. 1999;21(1):11-5. 
23. Qutishat AS. Medical laboratory quality and accreditation in Jordan. Clin Biochem. 2009;42(4-
5):256-8. 
24. Schneidman M DR, Carter J. Laboratory professionals in Arica: The backbone of qaulity 
diagnostics. 2014. 
25. Woodcock S, Fine G, McClure K, Unger B, Rizzo-Price P. The role of standards and training in 
preparing for accreditation. Am J Clin Pathol. 2010;134(3):388-92. 
26. Justman JE, Koblavi-Deme S, Tanuri A, Goldberg A, Gonzalez LF, Gwynn CR. Developing 
Laboratory Systems and Infrastructure for HIV Scale-Up: A Tool for Health Systems 
Strengthening in Resource-Limited Settings. Jaids-J Acq Imm Def. 2009;52:S30-S3. 
27. Fonjungo PN, Kebede Y, Messele T, Ayana G, Tibesso G, Abebe A, et al. Laboratory equipment 
maintenance: a critical bottleneck for strengthening health systems in sub-Saharan Africa? J 
Public Health Policy. 2012;33(1):34-45. 
28. Odhiambo F, Galgalo T, Wences A, Muchemi OM, Kanyina EW, Tonui JC, et al. Antimicrobial 
resistance: capacity and practices among clinical laboratories in Kenya, 2013. Pan Afr Med J. 
2014;19:332. 
29. Shin SS, Yagui M, Ascencios L, Yale G, Suarez C, Quispe N, et al. Scale-up of multidrug-resistant 
tuberculosis laboratory services, Peru. Emerg Infect Dis. 2008;14(5):701-8. 
30. Abimiku AG, Institute of Human Virology UoMSoMPP. Building laboratory infrastructure to 
support scale-up of HIV/AIDS treatment, care, and prevention: in-country experience. Am J Clin 
Pathol. 2009;131(6):875-86. 
31. Hamel DJ, Sankale JL, Samuels JO, Sarr AD, Chaplin B, Ofuche E, et al. Building laboratory 
capacity to support HIV care in Nigeria: Harvard/APIN PEPFAR, 2004-2012. Afr J Lab Med. 
2015;4(1). 
32. Malkin R, Keane A. Evidence-based approach to the maintenance of laboratory and medical 
equipment in resource-poor settings. Med Biol Eng Comput. 2010;48(7):721-6. 
33. Simundic AM, Bilic-Zulle L, Nikolac N, Supak-Smolcic V, Honovic L, Avram S, et al. The quality of 
the extra-analytical phase of laboratory practice in some developing European countries and 
Mexico - a multicentric study. Clin Chem Lab Med. 2011;49(2):215-28. 
34. Elbireer A, Gable AR, Jackson JB. Cost of Quality at a Clinical Laboratory in a Resource-Limited 
Country. Labmedicine. 2010;41(7):429-33. 
35. Herva E, Sombrero L, Lupisan S, Arcay J, Ruutu P. Establishing a laboratory for surveillance of 
invasive bacterial infections in a tertiary care government hospital in a rural province in the 
Philippines. Am J Trop Med Hyg. 1999;60(6):1035-40. 
36. Dacombe RP, M;  Kachiza,C;  Chisuwo, L;  Samuti, Dambe,GI;  Ramsay, AR; Mundy,C;  Suarez,PG;  
Mann ,GH;  Squire, SB. Refurbishing the tuberculosis reference laboratory in Malawi to conform 
to international biosafety guidance. 2012. 
37. Mbah H, Ojo E, Ameh J, Musuluma H, Negedu-Momoh OR, Jegede F, et al. Piloting laboratory 
quality system management in six health facilities in Nigeria. PLoS One. 2014;9(12):e116185. 
38. Yao K, Maruta T, Luman ET, Nkengasong JN. The SLMTA programme: Transforming the 
laboratory landscape in developing countries. Afr J Lab Med. 2014;3(3). 
39. Yao K, McKinney B, Murphy A, Rotz P, Wafula W, Sendagire H, et al. Improving quality 
management systems of laboratories in developing countries: an innovative training approach 
to accelerate laboratory accreditation. Am J Clin Pathol. 2010;134(3):401-9. 
40. Andiric LR, Massambu CG. Laboratory quality improvement in Tanzania. Am J Clin Pathol. 
2015;143(4):566-72. 
22 
 
41. Datema TA, Oskam L, van Beers SM, Klatser PR. Critical review of the Stepwise Laboratory 
Improvement Process Towards Accreditation (SLIPTA): suggestions for harmonization, 
implementation and improvement. Trop Med Int Health. 2012;17(3):361-7. 
42. Banyard AC, Horton DL, Freuling C, Muller T, Fooks AR. Control and prevention of canine rabies: 
the need for building laboratory-based surveillance capacity. Antiviral Res. 2013;98(3):357-64. 
43. Njelesani J, Dacombe R, Palmer T, Smith H, Koudou B, Bockarie M, et al. A systematic approach 
to capacity strengthening of laboratory systems for control of neglected tropical diseases in 
Ghana, Kenya, Malawi and Sri Lanka. PLoS Negl Trop Dis. 2014;8(3):e2736. 
44. World Health Organisation. Maputo Declaration2008 12/1/16. Available from: 
http://www.who.int/diagnostics_laboratory/Maputo-Declaration_2008.pdf. 
45. Serhan F. Building Laboratory Capacity to Support the Global Rotavirus Surveillance Network. 
Mmwr-Morbid Mortal W. 2013;62(20):409-12. 
46. Bennett DE, Myatt M, Bertagnolio S, Sutherland D, Gilks CF. Recommendations for surveillance 
of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther. 
2008;13 Suppl 2:25-36. 
47. Hull BP, Dowdle WR. Poliovirus surveillance: building the global Polio Laboratory Network. J 
Infect Dis. 1997;175 Suppl 1:S113-6. 
48. Featherstone DA, Rota PA, Icenogle J, Mulders MN, Jee Y, Ahmed H, et al. Expansion of the 
Global Measles and Rubella Laboratory Network 2005-09. J Infect Dis. 2011;204:S491-S8. 
49. Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A, et al. Epidemiology of 
antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance 
Surveillance): an updated analysis. Lancet. 2006;368(9553):2142-54. 
50. Bertagnolio S, Derdelinckx I, Parker M, Fitzgibbon J, Fleury H, Peeters M, et al. World Health 
Organization/HIVResNet Drug Resistance Laboratory Strategy. Antivir Ther. 2008;13 Suppl 2:49-
57. 
51. Sanchez JL, Johns MC, Burke RL, Vest KG, Fukuda MM, Yoon IK, et al. Capacity-building efforts by 
the AFHSC-GEIS program. BMC Public Health. 2011;11 Suppl 2:S4. 
52. Borchert JN, Tappero JW, Downing R, Shoemaker T, Behumbiize P, Aceng J, et al. Rapidly 
Building Global Health Security Capacity - Uganda Demonstration Project, 2013. Mmwr-Morbid 
Mortal W. 2014;63(4):73-6. 
53. Yin JH, Yan H, Huang F, Li M, Xiao HH, Zhou SS, et al. Establishing a China malaria diagnosis 
reference laboratory network for malaria elimination. Malaria J. 2015;14. 
54. Hendriksen RS, Mikoleit M, Carlson VP, Karlsmose S, Vieira AR, Jensen AB, et al. WHO Global 
Salm-Surv external quality assurance system for serotyping of Salmonella isolates from 2000 to 
2007. J Clin Microbiol. 2009;47(9):2729-36. 
55. Land S, Zhou J, Cunningham P, Sohn AH, Singtoroj T, Katzenstein D, et al. Capacity building and 
predictors of success for HIV-1 drug resistance testing in the Asia-Pacific region and Africa. J Int 
AIDS Soc. 2013;16:18580. 
56. Mbwambo K, Koch M. Establishing PT schemes in developing countries: examples from Africa. 
Accredit Qual Assur. 2012;17(4):379-82. 
57. Parkin N, Bremer J, Bertagnolio S. Genotyping External Quality Assurance in the World Health 
Organization HIV Drug Resistance Laboratory Network During 2007-2010. Clinical Infectious 
Diseases. 2012;54:S266-S72. 
58. Frean J, Perovic O, Fensham V, McCarthy K, von Gottberg A, de Gouveia L, et al. External quality 
assessment of national public health laboratories in Africa, 2002-2009. B World Health Organ. 
2012;90(3):191-9. 
59. Holloway K, Mathai E, Gray A, Community-Based Surveillance of Antimicrobial U, Resistance in 
Resource-Constrained Settings Project G. Surveillance of antimicrobial resistance in resource-
constrained settings - experience from five pilot projects. Trop Med Int Health. 2011;16(3):368-
74. 
60. Diaz HM, Perez MT, Lubian AL, Nibot C, Cruz O, Silva E, et al. HIV detection in Cuba: role and 
results of the National Laboratory Network. MEDICC Rev. 2011;13(2):9-13. 
23 
 
61. Patel ND, Rade K, Dave PV, Pujara K, Solanki RN, Vegad MM, et al. Impact of the RNTCPIRL-EQA-
OSE visits on quality of sputum smear microscopy services of Gujarat, India. Indian J Tuberc. 
2012;59(1):12-7. 
62. Van Rie A, Fitzgerald D, Kabuya G, Van Deun A, Tabala M, Jarret N, et al. Sputum smear 
microscopy: evaluation of impact of training, microscope distribution, and use of external 
quality assessment guidelines for resource-poor settings. J Clin Microbiol. 2008;46(3):897-901. 
63. Marinucci F, Manyazewal T, Paterniti AD, Medina-Moreno S, Wattleworth M, Hagembe J, et al. 
Impact of horizontal approach in vertical program: continuous quality improvement of malaria 
and tuberculosis diagnostic services at primary-level medical laboratories in the context of HIV 
care and treatment program in Ethiopia. Am J Trop Med Hyg. 2013;88(3):547-51. 
64. Jiang Y, Qiu M, Zhang G, Xing W, Xiao Y, Pan P, et al. Quality assurance in the HIV/AIDS 
laboratory network of China. Int J Epidemiol. 2010;39 Suppl 2:ii72-8. 
65. Gaydos CA, Rizzo-Price PA, Balakrishnan P, Mateta P, Leon SR, Verevochkin S, et al. Impact of 
international laboratory partnerships on the performance of HIV/sexually transmitted infection 
testing in five resource-constrained countries. Int J Std Aids. 2011;22(11):645-52. 
66. Elyan DS, Monestersky JH, Wasfy MO, Noormal B, Oyofo BA. Capacity building of public health 
laboratories in Afghanistan: challenges and successes (2007-2011). E Mediterr Health J. 
2014;20(2):112-9. 
67. Najjar-Pellet J, Machuron JL, Bougoudogo F, Sakande J, Sow I, Paquet C, et al. Clinical laboratory 
networks contribute to strengthening disease surveillance: The RESAOLAB Project in West 
Africa. Emerg Health Threats J. 2013;6. 
68. Cannas A, Paglia MG, Sakhoo DC, Vairo F, Doulla B, Nguhuni B, et al. Strengthening tuberculosis 
diagnosis in a low-resource setting: experience learned in Dodoma, Tanzania. J Infect Dev 
Countr. 2013;7(9):676-9. 
69. Seimenis A. Capacity building for zoonotic and foodborne diseases in the Mediterranean and 
Middle East regions (an intersectoral WHO/MZCP proposed strategy). Int J Antimicrob Agents. 
2010;36 Suppl 1:S75-9. 
70. Wertheim HF, Puthavathana P, Nghiem NM, van Doorn HR, Nguyen TV, Pham HV, et al. 
Laboratory capacity building in Asia for infectious disease research: experiences from the South 
East Asia Infectious Disease Clinical Research Network (SEAICRN). PLoS Med. 
2010;7(4):e1000231. 
71. Sweeney S, Obure CD, Maier CB, Greener R, Dehne K, Vassall A. Costs and efficiency of 
integrating HIV/AIDS services with other health services: a systematic review of evidence and 
experience. Sex Transm Infect. 2012;88(2):85-99. 
72. Mbah H, Negedu-Momoh OR, Adedokun O, Ikani PA, Balogun O, Sanwo O, et al. Implementing 
and measuring the level of laboratory service integration in a program setting in Nigeria. PLoS 
One. 2014;9(9):e107277. 
73. Massambu C, Mwangi C. The Tanzania experience: clinical laboratory testing harmonization and 
equipment standardization at different levels of a tiered health laboratory system. Am J Clin 
Pathol. 2009;131(6):861-6. 
74. Hamers RL, Straatsma E, Kityo C, Wallis CL, Stevens WS, Sigaloff KC, et al. Building capacity for 
the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to 
Evaluate Resistance network. Clin Infect Dis. 2012;54 Suppl 4:S261-5. 
75. Young DS. Progressing towards laboratory accreditation in developing countries. Afr J Med Med 
Sci. 2010;39(4):333-40. 
 
24 
 
Annex 1: Data from Key Informant Interviews 
 
Interview 
Number 
Programmes involved in Types of activities 
carried out 
Outcomes Challenges/Concerns 
1 Involved in two types of programs. 1) Health system perspective 
based, looking at lab systems and networks which involves 
strategic planning at national level. For example, in Central Asia 
and former Soviet regions (Moldova, Uzbek, Turkmenistan etc). 
2) Current situation analysis (SWOT) - doing system assessment 
which has two components- system one and a facility one. Africa 
Society for Public health score card for lab project. JEE Project 
parallel with global health security agenda which involves system 
analysis/SWOT and also policy and strategic analysis. Better lives 
for better health- EQA, training curriculum in Moldova, 
Tajikistan, Russia. The Facility based programs focus on QM, for 
example- using GLI and LQIS tools and involves direct 
implementation in Uganda (2008-2014). Another one in Tanzania 
and Vietnam 
Strategic planning, 
SWOT analysis, 
training of the 
mentors, trainers, 
quality management 
Uganda- 
National TB 
laboratory 
became Supra-
national 
reference lab 
with ISO 15189 
accreditation 
with South 
Sudan and 
Somalia utilising 
services. 
Sustainability and political commitment are 
key concerns. Also making them realise that 
it is 'their (local)' Quality management not 
ours and that teams are there for 
mentoring and not necessarily 
implementing. The difficulties of programs 
like SLPTA is that it parachutes people for 
quick service and hence challenges to local 
capacity building. If implementation is 
successful and robust system is achieved- 
challenges appear in terms of expectations 
(request for research) and workload, raising 
issues with regards to staff management or 
generate funds. Active lab 
leadership/manager is critical. For example, 
Moses, director of TB program. For policy 
and strategic developments, not enough 
funds are available, or not properly trained 
staff to can take up advocacy for lab 
management and quality assurance, most 
LMICs do not have specific program 
2 Started with TB lab strengthening work to develop National TB 
Lab quality management in Uganda and Vietnam. Was mentoring 
project but not necessarily embedded in the NTBL work. It 
involved technical training for one week/four times a year. It also 
involved distance monitoring, bringing TB labs for ISO15189 
accreditation standards. The Global Laboratory Initiative (GLI) for 
TB was initiated to provide development and uptake of practical 
guidance and tools for high quality TB diagnostic networks. It 
provides a roadmap for taking step by step process for QM 
systems in TB. The GLI tool led to development of LQIS which is 
free tool in the form of a website that provides a stepwise plan 
  Until Ebola happened lab capacity 
strengthening was not a major priority for 
the governments. Developing tools is not a 
major challenge but implementation is. 
Human resources are key concerns- work 
overload, continuity, and keeping 
motivation about continuity to same high 
standards is very difficult. At PHC level, 
maintenance and supply of reagents, 
calibration of equipment is an issue. 
Equipment donation is not difficult and 
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to guide medical laboratories towards implementing a quality 
management system in compliance with ISO 15189. LQIS is more 
generic in nature, and contains a checklist that countries can 
flexibly adopt to their needs, and can be translated. Also provide 
training of using LQIS, introducing QM systems on site in 
different countries. Since ISO is expensive and difficult to 
achieve, the focus is only at national level or regional level labs. 
At primary health level- standardisation of tests, carrying out 
pre-analytical assessment is important. Technical Assistance at 
lower levels is difficult as it depends on several other factors 
(context based).  Donor money is usually only provided for 
national or central level 
several organisations donate, however 
many times correct equipment is not 
received or other supply issues (reagents 
etc) to use equipment is not well thought. 
You need to work within the system you 
got, but challenges come from human 
resources- motivation of staff, political and 
organisational commitment. 
3 1. TB Supra national reference lab. It also has surveillance data 
on the emergence of TB resistance. Ref lab is linked with NRLs 
and provides support with QA of DST. It has formal agreements 
with national labs for support of new diagnostics. 2. Global Lab 
initiative with partner countries. 3 Expand TB involves rapid 
rolling out of new diagnostics at lower levels (?) 
Various tools 
developed for 
partner countries 
such as biosafety, 
accreditation, 
effectiveness of the 
lab network, 
supporting 
consultants to 
provide training and 
technical assistance. 
The effectiveness of 
the programs 
measured through 
several indicators- 
such as PT, 
improvement in case 
notification, RDT. 
 WHO makes recommendations and 
countries roll out, costs are high and uptake 
of programs may not be as wide. Policy 
change at country level is challenging, for 
example GeneXpert for TB diagnosis. 
Ensuring sustainability is difficult- at the 
end of donor money, govts stop the run of 
the programs. The challenge is to have 
interventions at the lowest tier of health 
system, and point of care tests that are long 
term sustainable for local needs- where 
manufacturers need to optimise 
measurements. For example, in pulmonary 
TB point of care testing is an issue. 
Manufacturers need to make too many 
manipulations with sputum samples, and 
quality management and biosafety needs to 
be maintained otherwise contamination is 
easy. WHO can only provide policy and 
implementation guidance but cannot 
implement programs, has to rely on 
partners. 
4 Recently have been involved in developing lab capacity in East 
Africa where there were gaps in TB control program 
  1. Human Resources a key concern- quality 
of competencies is underdeveloped. 
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(http://www.worldbank.org/en/results/2016/06/07/east-africa-
public-health-laboratory-power-of-networking). Involved 5 
countries- Rwanda, Tanzania, Uganda, Kenya, Burundi. All 
countries have high burden of disease out breaks and high 
burden of TB and emerging MDRTB. Designed a network of 32 
labs, each country taking a lead one technical aspect. This also 
involved drug resistance monitoring. In last 5 years since 2009 
Uganda and Rwanda have developed state of the art labs, and 
some got 1 or 2 stars for ISO15189 accreditation. Besides 
infrastructure, the project also helped in RDTs, preservice and in-
service training. The network was developed on the premise of 
knowledge sharing between those five countries and support 
each other in different capacity building aspects. The 
harmonisation and standardisation of training programs, 
materials, SoPs were crucial for information exchange. Provide 
onsite training, training of trainers programs. FELTP is a gold 
standards training program for epidemiologists. ASLM focuses on 
strengthening lab workforce by training and certification through 
standardised frameworks. World Bank works only at tertiary 
level hospitals. It is important that the design of the programs 
should be simple but very focused. Offshoot research is 
extremely important and powerful tool within programs to 
identify issues in local areas. Sometimes disease focused lab 
strengthening may not beneficial for expanding research. Also 
involved in developing lab capacity for NCDs. Phase 1 is 
diagnostics focused. For example- cancer related capacity. Only 
handful of hospitals do cancer diagnosis in urban hospitals or 
private sector hospitals. People arrive for diagnosis at very late 
stage or had very bad prognosis. Rolling out of basic pathology 
services at lower levels is considered. Proper biopsy and samples 
sent to referral labs within time is crucial. Telephathology 
programs are being considered using electronic computerised 
systems. For example- in Rwanda. Access to services, early 
prevention and detection of cervical cancer with other maternal 
health programs. 
Standardisation and harmonisation has a 
side issue of staff retention, they move to 
other places and there is 'labour 
mobilisation'. Turnover of HR is an issues. 
The relationships between scientists and 
clinicians is usually tense although things 
are improving, so it is preferable that 
programs should be integrated with 
hospitals.2. Measuring effectiveness and 
impact is very challenging. 3. Sustainability- 
both financial and institutional 
sustainability is key, maintaining capacity, 
and countries taking ownership of the 
programs and maintain capacity and create 
Centres of Excellence. Example of 
sustainability- Uganda Supranational 
Laboratory (NTBL) that provide support to 5 
countries. Such activities require individual 
champions who have the drive and 
determination. 
5 Mixture of strengthening the service and research- combined 
both. 1995-2002 worked in Vietnam (UNAIDS_ in Ho Chi Minh 
Cambodia Produced 
SOPs, Vietnam- 
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infectious disease hospital. Based within hospital and laboratory, 
research lab based within routine lab- members keep rotating. 
New programs for supporting lab methods. For Vietnam settings 
very high quality lab. Same in Cambodia- children's hospital 
(2010-12), same setting microbial lab, introduce csf culture, 
culture for other things. focus on QC/QA. Similar thing currently 
in Philippines- infectious disease hospital in Manila, 
strengthening lab methods, routine testing. So working in 
routine diagnostic labs in different countries (Japanese govt 
fund) (WT fund). In Malawi and Vietnam worked on the 
laboratory part of the TB program to strengthen central ref labs 
to help them with surveillance of drug resistance of TB, and 
improving lab safety- physical structure and lab safety. WT 
funding lab research than strengthening- but can't do research 
without lab strengthening. UNAIDs have program of lab 
strengthening for TB, for surveillance of MDRTB. Provided 
training at all levels (national/regional) 
training, training 
material, practical 
teaching, 
interpreting results. 
Cambodia and 
Vietnam- 
believable 
results from the 
lab with high 
QA/QC. With TB 
in Malawi- 
MDRTB 
surveillance 
project, how 
much MDRTB 
was present. 
Completed 
survey. 
Opportunity to 
secure funding 
for refurbishing 
lab. Vietnam- 
labs could do 
QA/QC based 
work (5 labs). 
1. The lack of resources- in TB program, 
routine diagnostic labs. With WT funds in 
labs in Vietnam and Cambodia- able to 
achieve. But many labs struggle with 
resources to do tests or what they want to 
do. Resources for reagents, equipment to 
do safe job particularly TB labs which is big 
investment. 2.Access to the materials- 
access to QC strains, reagents. Information 
with regards to guidelines- for example if 
antimicrobial susceptibility testing that 
needs to be done according to guidelines. 
Two main system- EU system is free online 
and US CLSI which many use you have to 
pay. Labs can't pay for that and rely on old 
guidelines.   CLSI revises every year and for 
each new edition you need to pay for it. 
Labs part is often forgotten and neglected 
compared to the other parts of the system. 
Sometimes easier to focus on one labs, on 
national level- eg. Vietnam with 5 labs 
together challenging as each lab had 
different issues and problems, travelling 
around. Challenge to standardise methods 
across all labs.  Funding and costings about 
national program, also within each lab- 
issues about what labs should be doing. 
One big issue with TB- safety in labs, 
particularly sensitivity testing, there are real 
risk to lab staffs. There are different 
approaches to address lab, for example - 
the lab is not perfect and completely safe 
from western lab point. One approach is to 
say that is what we got and we try to 
improve within the constraints of facilities 
available. Another approach is to say this is 
unacceptable. People from west criticise 
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that it is unethical to do it in labs with 
limited facilities and should be based on 
western standards. My view is usually being 
first- that whatever we got let’s try to make 
it safe as much as we can. BSL-3 level labs 
for developing countries are expensive to 
build and run and technically difficult and 
may not be within technical capability of 
local people. What WHO initially discussed 
that if you can't have BSL3 lab- can we have 
BSL2+ lab (more than BSL 2 less than BSL3). 
Not sure if WHO has produced new lab 
safety manual that suggests that. For TB lot 
of labs/countries struggle. One has to be 
realistic about what should be done. Try 
not to replicate western lab in resource 
poor settings. People do not trust the lab 
results in poor labs, as labs often do not 
have proper QC/QA. Even simple things like 
Malaria smear can't be done properly. So 
better to have a lab that can do few but 
good tests than lots of tests but not well. 
Focus on diseases of public health 
importance and not everything like a 
western lab would do. Should adapt to local 
situation but you cannot adapt quality. 
have to stick to the quality. HR- salaries in 
govt labs not good, in Malawi- people move 
to private labs, or brain drain from south to 
north. For example a 1000 bed govt 
hospital in Bangladesh did not have a 
functioning lab, but was surrounded by 
private labs increasing competition to 
attract patients (even entering wards) or 
through doctors nexus for business. Even 
private labs very bad quality. If you are 
doing surveillance for resistance, you need 
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to also look into private labs because that is 
where people go. 
6 Have worked previously with LSTM so LSTM aware of the 
programs involved in. There is a relative freedom to carry out 
projects of one's own interest, programs are donor driven in the 
US (a big limitation. Worked on both USAID and CDC funded 
projects. 
  Interview focussed on the different 
challenges in programs. USAID: programs 
are disease control based such as HIV/AIDS, 
TB, Malaria and lab component is 
embedded in it. CDC projects are stand 
alone and decided by CDC priorities rather 
than what is needed. Most US programs do 
not allow operational studies and emphasis 
is on service delivery, capacity building for 
returns. Sustainability is a concern although 
things are slightly changing, 10 yrs ago 
technical assistance and donors had to take 
ownership for sustainability but now 
countries are expected to take control. CDC 
started PEPFAR 1 in 2003, and PEPFAR 2 in 
2008. The difficulty in PEPFAR is that it 
assumes that all countries should have 
same/similar lab conditions and ignores 
socio-economic and cultural conditions. The 
focus is on lab capacity inside the four walls 
of the lab, such technical development, 
linkages to quality management and 
accreditation stds etc and expect labs to 
come up with same stds in resource limited 
settings also. Example of Challenge in 
PEPFAR program in Kenya supported by 
MSH. Only oversight was provided by US 
and local Kenyan team was responsible for 
capacity building. However program was 
under the control of CDC, which developed 
national policy plan to implement taking a 
very top down approach without any 
ground work on local conditions. The focus 
in CDC is very much about technical 
component, biosafety issues. The program 
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required training two key lab personnel at 
different sites who would further carry out 
the training for others.  In Kenya despite 
the technical development in the labs, very 
hard to keep the staff motivated to carry on 
once the donors exit. MSH developed a 
leadership and management skills program 
for labs. It is not about labs per se but 
developing human resources so that there 
is an increased retention of staff and 
motivation to take ownership and capacity 
building from the countries. In Kenya 
political support and senior management 
support for staff motivation is lacking. WHO 
is dependent on donors and does not have 
its own money, so it focuses more on policy 
making, std setting. The Global lab 
initiative- designing tools for labs and then 
WHO relies on consultants to implement 
them locally. WHO-AFRO's lot of work is 
done by CDC, and although WHO West 
Pacific is more active but less attention is 
given to it. Sustainability is a key concern 
after donors leave. Programs are shut and 
countries do not take ownership for 
running the programs, due to the 
investments needed. Lab capacity 
strengthening is not just related to the 
structure of the lab alone but its 
sustainability requires substantial focus and 
planning about financial aspects- budgeting, 
leadership. In many poor countries the 
MoH rely on other ministries for budget 
(finance for example). Lab programs are 
more successful when they are embedded 
in system wide disease focussed programs. 
Access to labs is also difficult. CDC only 
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focuses on top-half of the labs in the 
system and not lower levels. The idea of 
strengthening labs is not enough rather the 
focus should be about making diagnosis 
sustainable. For example with TB 
GeneXpert diagnostic technology- the tests 
are heavily subsidized by donors. Difference 
has to be covered by the countries. Lab 
capacity is technology focussed and most of 
the time staff do not meet patients. 
7 Worked in WHO since 2004. Initially capacity building was 
integrated with infectious disease department but later created 
a specific unit for capacity strengthening of national labs. The 
focus in on epidemic born diseases just not HIV/NTD/TB/malaria. 
The focus has been on viral driven pathogens- H1N1/H5N1/Ebola 
but also have recent focus on plague and cholera. For example 
cholera in Haiti after the earthquake. Lyon Unit is not disease 
specific, Geneva unit is disease specific capacity strengthening. 
Take lab capacity strengthening in its entirety. Usually focus on 
NRLs or regional labs but occasionally hospital based labs also 
but diagnostic capacity strengthening only at national or 
provincial levels. Resistance capacity is included recently. AMR 
team is in Geneva but do not focus on lab capacity strengthening 
but we include lab capacity in our team. Within AMR- lab 
capacity at the interface between animal and human health. For 
example in Pasteur Institute a study in Cambodia focused on 
collecting specimens from animals (chickens?) to identify 
resistant strains in animals transferred to humans through food. 
The projects in WHO are both long and short term- depends on 
the donors and funding source. Major funders US govt, USAID, 
CDC, EC/EU, GIZ. French and Russian govts but never from DFID. 
Donors do not want to commit for 5 years in one attempt. 
Usually it is cyclical and every year grant is received.  Only Gates 
foundation gave 5 yrs grant and followed by EC for three years. 
As with regards to Technical projects- 20 million USD spent in 15 
years globally. Some strategic objectives have included- better 
organisation of NRLs, development of national lab policies, 
  Cyclical nature of grants is an obstacle for 
sustainability. Cannot do much in one year. 
Only can buy equipment and reagents but 
to bring change in workforce/policies and 
programs need longer term investment and 
ownership for the local labs is important for 
sustainability.2. Many labs are more 
interested in research and publication with 
WHO rather than investing time and effort 
in lab capacity strengthening. 3. 
Sustainability is a key concern-needs lots of 
investment in every aspect of lab from 
workforce to infrastructure.4. To create 
market for labs-need for clinicians to 
understand its importance and they should 
demonstrate the use of lab and advocate it. 
Clinicians and lab managers are not good in 
advocacy about labs so as to convince 
ministries for focus and investment.   
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coordination of labs at national level. It involves- creating 
national units/bureau focusing only on lab capacity 
strengthening within ministries who have a lab systems 
information such as structure and type of lab, public and private, 
academic or hospital based, types of diagnostic facilities. There is 
a need for licencing mechanisms and registration processes for 
the labs. The system of twinning training/sandwiched training for 
researchers from resource poor countries in rich countries does 
not work because they go back to their local environment, 
difficult to identify motivated staff so onsite training with 
available resources is good. Immediate loss of capacity as soon 
as donors exit because countries do not take ownership for 
sustainability; and there is a dependency mode even for 
equipment and reagent supply (from abroad), corruption and 
personal interests take over a few times. Need for local supply 
chain and creating networks regionally. For example-in Yemen a 
director of a hospital lab had supply issues of reagents in his 
place but across the street supplies were maintained in his own 
private lab. Patients do not trust on lab reports also because of 
their quality so there is no demand and hence no importance for 
govt. Improvement can be brought from UHC and medical 
insurance for lab testing, so that patients do not need to pay out 
of pocket and a demand can be created for govt to oblige. Need 
for economic studies on demand side lab improvement. Lab 
strengthening not enough, how to finance labs with a focus on 
quality is more urgent.  WHO also sends retired scientists as 
mentors and help labs to develop QMS systems, manuals and 
protocols. Another aspect of strengthening is in biosafety- 
developing biosafety manuals, in country guidelines and 
regulations. Top 3 priorities (personally) would be-Support 
countries in short term, focus on mentoring doctors and 
coaching to scientists for lab capacity and making ministries to 
realise the importance of good lab data in treatment. In parallel, 
developing national policies and regulations for labs such as 
licencing only when a certain criterion is met. Third would be to 
develop insurance systems that include lab testing to stop out of 
pocket payments, create demand for lab tests so that there is an 
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investment. Assessment of the effectiveness- by PT testing for 
example, accreditation achievement, number of labs 
participating annually in PT testing. WHO has done 12 yrs of PT 
testing but with catastrophic results-only one third of the labs 
could do proper susceptibility testing for bacterial pathogens. 
Reasons are same- outdated equipment, no reagents, lack of 
proper technical training for culturing; makes Antimicrobial 
susceptibility testing even more difficult. Viral labs better 
prepared than bacterial labs as donors focused only on viral labs 
as there were no vaccines or treatment for viral conditions 
compared to bacterial conditions for which we have antibiotics 
and secondly bacterial labs not important for rich countries so 
not big on their agenda for donation. 
8 GSK-Africa NCD open lab team launched a proposal back in Nov 
2014 to identify projects that were undertaking more research 
how various NCDs impact the African patient under grant 
funding Go-GRAM(?). An explicit requirement of the grant was to 
have a capacity strengthening component. Five projects in five 
different institutions in Africa shortlisted (3 yrs funding) - each 
has capacity strengthening integrated into it by design. This 
could include funding a PhD or MSc as part of the project, 
consultancy or mentoring in particular area- for example linking 
GSK statistician with local statistician in research team to 
strengthening statistical component of an application, support 
and training in lab kits, advice on selection of various genetic 
markers. There is no standard type, we just provide support on 
the request. One project is started and the rest four are in the 
contracting stage. Each project fits in the WHO definition of NCD 
cluster. GSK scientists involved from the beginning- including 
writing a good protocol for the project. We have visited each 
country to establish relationship between GSK scientists and the 
applicant to start that person to person contact. M&E framework 
for each project developed, also for overall program to assess 
the impact of the project and impact on scientific knowledge, 
expertise building at individual and institutional level. Some 
indicators include- no. of people trained, number of training 
events, types and roles of people trained, no. of people enrolled 
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in the program as a result of the grant GSK providing, number of 
workers trained on using equipment. Due diligence process was 
carried out- research environment was assessed on sites for 
initial start capabilities and identify what capacity building 
agenda of that project should be. At pregnant stage- From the 
institutions perspective- they were keen to portray institution in 
positive light that perhaps presented a risk that they might be 
obscuring some of the needs they might have so we needed to 
build a trust relationship where they were comfortable to open 
up. Many countries do not have experience of collaborating with 
private sector for building capacity. And to use private sector 
scientists for capacity building is an unfamiliar model for many 
countries so we had to convince that visits were not an audit 
rather to build relationship. From GSK side there were common 
themes (wrt to problems) that can be looked for future projects- 
institutional gaps (how to write good proposal, manage grant 
finances) and scientific gaps which GSK chose to focus on- 
technical support. Hoping that countries will build on training 
and continue after GSK exits. Trying to connect investigators with 
each other and try to create a network to give sustainability at 
the end of the three years once we finish. Encouraging south-
south collaboration. Our strategy was to learn from doing and 
learning together, living through it. GSK working with two other 
funders for another set of calls on same principles- Newton fund 
program with South African MRC and UK have selected 7 
projects in SA. 
9 Three different types of programs are conducted by AMREF. 1. 
Refresher course in laboratory services for lower level, technical 
staff. Conducted in Nairobi for 10 weeks, twice a year. Usually 
advertised on AMREF web pages, it is designed for district level 
or lower hospital lab workers. All disease types are focused and 
provide training in bacteriology, parasitology, serology, 
immunoassay etc. Normally 20-30 applications are received but 
can accommodate only 15. Participants need to find their own 
funds to attend.2. Medical Laboratory Practice and Management 
course: conducted for 5 and half months in three phases. Phase 
1 involves 2 months of training and hand on practical sessions. 
Training and 
mentoring- onsite 
facility based or a 
comprehensive 
program for all, 
designing training 
and diagnostic 
manuals, SOPs 
 1. Funding- for lower level courses where 
participants need to generate their own 
funds is challenging, even for lab 
management program sponsorship does 
not cover either local or international 
travels. Even after successful training 
implementation can be challenging because 
of lack of funds, therefore outcome and 
impact cannot be measured. 2. Logistical 
challenge- for lower staff training the 
technicians may need to close the lab for 
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Course material and self assessment checklist is provided for the 
tasks to be carried out. Phase 2 involves a two week residential 
training program in Nairobi using didactic approaches on 
leadership and mentoring. Phase 3 involves participants to 
develop action plans and implementation at their respective 
institutions for which AMREF provides technical support. This 
course attracts participants from regional or national level 
laboratories, for example HIV/AIDS and TB referral labs and some 
places have put quality assurance system to lead to ISO 
certification.  3. AMRF carries out in country 2 week short 
courses designed based on the needs of the facilities. The 
trainers and facilitators provide onsite training, for example 
malaria microscopy.  In 1997, external competency assessment 
of Malaria microscopy course was organised for competency 
assessment and also developed EQA programs at primary care 
levels where samples are sent with undisclosed results. 
few days which is not feasible, and for 
international participants issues such as 
visas requirements, lack of proper 
paperwork etc are common. 
10 1. Involved several projects. With MSH- a Columbia University 
supported project in Rwanda, Burundi, DRC, Ivory Coast, Ghana. 
The focus was on HIV/TB. Work involved strengthening MoH 
capacity in general but also on lab techniques such as viral load. 
Also involved with PMTCT. 2. Another project involved was on 
NTB to strengthening MDRTB with Global Fund, MSH, PEPFAR. 
These involved both infrastructure development and renovating 
labs to 2nd or 3rd Biosafety levels. At central level the lab(s) 
were completely renovated at two levels- a city hospital and a 
peripheral level hospital to BSL level 3 for TB. Capacity of NRL 
was developed with viral load for early infant diagnosis. And a 
separate Malaria molecular testing facility was created. 5 central 
labs were also developed with package of testing facilities (more 
than TB). These involved technical training, local training with 
manufacturers for preventative training and standardisation of 
equipment across all the countries. MoUs were signed with 
manufacturers with annual maintenance. 3. Also involved in 
human resource capacity building with HIV/TB. This involved 
curriculum development for nurses at national level for pre-post 
training programs. Development of guidance on standardisation 
of equipment. 4. Involved in National policy on RDT for MDRTB, 
 Establishment 
of panel testing 
in two hospitals 
in Rwanda, fully 
functional lab, 
use of 
GeneXpert 
machine for 
MDRTB. 
Challenges are local, vary country to 
country. Some places need start up from 
scratch and other need improvement. Now 
PEPFAR and Global Fund do not support 
infrastructure development. 2. High 
turnover of staff, people train abroad and 
move abroad so we need to start again. 
People are dedicated to different projects 
or departments within the same facility so 
dedication for one is not there. But can't 
train all 3. Rwanda is more organised in 
terms of supply and equipment 
maintenance compared to Ghana, Ethiopia 
and Burundi. No replacement or costs too 
high when equipment breakdown. 4. 
Effectiveness is hard to measure- use MSH 
tool for assessment which is similar to 
Makuto tool. MSH tool can be adopted 
according to the project. 5. Prioritisation of 
projects depends on fund and type of 
infrastructure needed. Sometimes also just 
36 
 
vertical programs for malaria/TB and focus on community level 
approaches. Developed lab materials for health care workers 
with Columbia university for rapid testing. Community level ToT 
program for NTBP which was a cascade program and support 
was provided to trainers for transport/accommodation when 
they cascaded training at community level. Within this program, 
in collaboration with Tropical Institute Belgium there was a 
sandwiched program to train medical doctors or scientists for 
BSL-3 level training for one month. In Ethiopia working with 
Institute of Public health to have NRL and HR capacity 
development in HIV/TB/malaria. This also involve establishing an 
MSc/PhD program at university hospital and sending candidates 
for training for some time in specific techniques on virology, 
parasitology and microbiology. 
do advocacy work which has no linkages 
with development of NRLs or some level 
labs in vertical programs. 6. Many times 
MoH programs have no linkages with lab 
development. MoH is usually dominated by 
clinicians who have not much interest in 
labs. 7. Countries do not take ownership 
and very much donor dependant (get used 
to advice from donors and technical 
experts) for example 68% of MoH staff in 
Rwanda are funded by external donors; but 
in MSH ownership is key focus on the 
programs. 
11 Between Jan2012-Nov2014 was in WHO tech office in Lyon with 
lab strengthening biosafety team. Developing tools, training 
manuals, guidelines (QMS) , online SLIPTA tools, tool 
management guidelines. In country training involved assessment 
and training based on QMS rather than teaching basic lab 
techniques. How the tests should be done, SOPs, record keeping, 
rapid reporting tp clinicians. Provided country level training in 
Yemen and Sudan. The focus on the trainings have been for 
public health laboratories rather than clinical labs training. 
Majority of the cases MOHs do not understand the importance 
of public health labs. So we change the type of language we use 
for convincing ministries. For example-instead of saying that your 
lab achieved only 64% score on QMS which lot of ministries think 
is a good score, we state it means one in four samples is giving 
wrong diagnosis so as to convey the messages. WHO does not 
take money from donors if it does not wish to. However many 
donor agencies also have operational capacity, for example CDC 
who can direct their own plans, plus also donate to WHO. For 
sustainability-local training and mentoring of the staff in good 
microbiology techniques.   
Not involved in the 
assessment of the 
effectiveness of 
program. Though 
during the training, 
at the end of the 
session we ask for 
general comments 
and advice how 
things can be made 
better in training. 
WHO only provides 
service on request, 
countries sometimes 
carry out their own 
assessments.   
 Lack of women in lab leadership roles. For 
example in Yemen, Sudan, Egypt several 
women in the labs but most of them at 
what men perceived to be low level jobs. In 
low income countries such as Laos PDR- 
system is very basic so challenging to 
implement and train people, language 
barriers, infrastructure issues so even 
within all LMICs, situation is very different. 
2. Country needs do not necessarily match 
with what donor wants. And as LMICs are 
dependent on future donations, they 
accept the donor money. Not an equitable 
partnership. For example, for one lab in 
Lao/Vietnam- 6 PCR were donated for 6 
different diseases and working in silos. 
Donors sometimes also work in conflict 
with each other, and local labs struggle to 
balance different donor demands. Donor 
coercion exists. Donor money sometimes 
creates a patch rather than a 
comprehensive, systematic development of 
the lab. 3. WHO twinning program not very 
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successful. The expectation that the stds of 
the labs in poor countries will be similar to 
rich countries is factually incorrect- and 
there is a brain drain. For example- during 
Ebola in Sierra Leone, people said there are 
more doctors of Sierra Leone outside Sierra 
Leone than in the country. There is a need 
for a system to be in place where career 
pathways of researchers should be tied 
with the grant to serve in-country for a 
certain period of time. ROSO- return to 
service obligation (as seen in Australian 
military). Government needs to provide an 
attractive environment to stop brain drain, 
mutual respect and appreciation, gender 
balance. 
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Annex 2:  Geographical coverage, disease context and operational level of capacity strengthening of studies found in the literature 
 
Study 
Number 
Title Year of 
publication  
Country/Regional Context Disease Context and 
funder 
Operational level of 
capacity strengthening  
1 Strengthening national 
laboratories health systems in the 
Caribbean Region 
2012 Caribbean- St. Lucia, St Vincent, 
The Grenadines, Grenada, 
Antigua, Barbuda, St. Kitts and 
Nevis, Dominica, Barbados, 
Trinidad and Tobago, Belize, 
Suriname, Jamaica, the Bahamas, 
HIV - PEPFAR 
 
Societal  
2  Building laboratory infrastructure 
to support scale of HIV/AIDS 
treatment, care and function 
2009 Nigeria- 26/36 states in Nigeria HIV/TB and OIs Primary, secondary, 
tertiary 
3 Animal health: harmonisation and 
distribution of pathogen 
detection and differentiations 
tools 
2008 East Europe, Asia 
n(Pakistan/China), Middle East 
and Africa 
animal pathogens-
Transboundary animal 
diseases (Ringerpest, 
FMD PPR) CCHF 
Regional and international 
4 Standardisation of pathology 
laboratories in Pakistan: problems 
and prospects 
2009 Pakistan all national 
5 Laboratory quality improvement 
in Tanzania 
2015 Tanzania All/US Global Health 
Initiative (GHI) 
Regional and district 
6 Control and prevention of canine 
rabies: the need for building 
laboratory based surveillance 
capacity 
2013 global rabies International, national and 
local 
7 World Health 
Organisation/HIVResNet drug 
resistance laboratory strategy 
2008 International/global HIV WHO/national 
governments 
8 Rapidly building Global Health 
Security Capacity- Uganda 
Demonstration Project, 2013 
2014 Uganda TB, Cholera and Ebola/ Primary, secondary, 
tertiary 
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Study 
Number 
Title Year of 
publication  
Country/Regional Context Disease Context and 
funder 
Operational level of 
capacity strengthening  
9 Rehabilitating public health 
infrastructure in post conflict 
setting: epidemic prevention and 
preparedness in Kosovo 
2001 Kosovo All infectious diseases/ 
WHO and IRC 
Primary, secondary, 
tertiary 
10 Strengthening tuberculosis 
diagnosis in a low-resource 
setting: experience learned in 
Dodoma, Tanzania 
2013 Tanzania TB Regional 
11 Non traditional security and 
infectious diseases in ASEAN: 
going beyond the rhetoric of 
securitisation to deeper 
institutionalisation 
2008 ASEAN countries Pandemic 
Influenza/WHO and 
national governments 
National and regional 
12 Building public health capacity in 
Afghanistan to implement the 
international health regulations: a 
role of security forces 
2010 Afghanistan All infectious 
diseases/WHO and 
USA 
Primary, secondary and 
tertiary 
13 Strengthening public laboratory 
service in sub-Saharan Africa: 
Uganda case study 
2011 Uganda HIV and STIs/PEPFAR National and regional 
14 Capacity building of public health 
laboratories in Afghanistan: 
challenges and successes 
2014 Afghanistan All diseases/ US Naval 
Medical Research Unit 
3 
Local and regional 
15 Building laboratory capacity to 
support the global rotavirus 
surveillance network 
2013 global rotavirus diseases- 
diarrhoea/ WHO 
global 
16 Expansion of global measles and 
rubella laboratory network 2005-
2009 
2011 global Measles and Rubella/ 
WHO 
subnational, national, 
regional, global 
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Study 
Number 
Title Year of 
publication  
Country/Regional Context Disease Context and 
funder 
Operational level of 
capacity strengthening  
17 Assisting cytopathology training in 
medically under-resourced 
countries 
2011 Africa- Uganda, Nigeria, Kenya, 
Tanzania, South Africa 
All/ All levels 
18 Impact of international laboratory 
partnerships on the performance 
of HIV/sexually transmitted 
infection testing in five resource-
constrained countries 
2011 China, India, Peru, Russia, 
Zimbabwe 
HIV/STI (HSV2, syphilis, 
Chlamydia, 
gonorrhoea, 
trichonomas vaginalis/ 
NIH 
local 
19 The World Health Organisation 
African Regional Laboratory 
Accreditation Process 
2010 Africa All infectious 
diseases/WHO 
All levels 
20 Building laboratory capacity to 
support HIV care in Nigeria: 
Harvard/APIN PEPFAR, 2004-2012 
2015 Nigeria HIV/PEPFAR Primary, secondary, 
tertiary 
21 Building capacity for the 
assessment of HIV drug 
resistance: experiences from the 
pharmaccess african studies to 
evaluate resistance network. 
2012 South Africa, Zambia, Zimbabwe, 
Uganda, Kenya, Nigeria 
HIV  
22 Surveillance of antimicrobial 
resistance in resource-constricted 
settings- experience from five 
pilot projects 
2010 India (Delhi, Mumbai, Vellore) 
South Africa (Brits, Durban) 
  
23 WHO global Salm-Surv external 
quality assurance system for 
serotyping of salmonella isolates 
from 2000 to 2007 
2009 Global diarrhoeal 
illnesses/WHO 
national 
24 Developing laboratory systems 
and infrastructure for HIV scale 
up: a tool for health systems 
2009 Africa HIV/PEPFAR All levels 
41 
 
Study 
Number 
Title Year of 
publication  
Country/Regional Context Disease Context and 
funder 
Operational level of 
capacity strengthening  
strengthening in resource limited 
settings 
25 Strengthening systems for 
communicable disease 
surveillance: creating laboratory 
network in Rwanda 
2011 Rwanda All/ all 
26 Capacity building and predictors 
of success for HIV1 drug 
resistance testing in the Asia-
Pacific Region and Africa 
2013 Asia (India, China, South Korea, 
Japan, Thailand, Vietnam, 
Taiwan, Malaysia, Singapore). 
Africa (South Africa, Uganda) 
HIV/ amfAR, Dutch 
Ministry of foreign 
affairs 
All levels 
27 Evidence-based approach to the 
maintenance of laboratory and 
medical equipment in resource 
poor settings 
2010 China, Dominican Republic, El 
Salvador, Ghana, Haiti, Honduras, 
Nicaragua, Sierra Leone, Sudan, 
Tanzania, Ukraine. 
 all 
28 Impact of horizontal approach in 
vertical program: continuous 
quality improvement of malaria 
and TB diagnostic services at 
primary level medical hospitals in 
the context of HIV care and 
treatment program in Ethiopia 
2013 Ethiopia HIV, malaria, TB/ 
PEPFAR 
Primary care 
29  Implementation of quality system 
approach for laboratory practice 
in resource-constrained countries 
2005 Low resource countries HIV/US CDC- Global 
AIDS Programme (GAP) 
All levels 
30 Working toward a sustainable 
laboratory quality improvement 
programme through country 
ownership: Mozambique's SMLTA 
story 
2014 Mozambique All diseases/ WHO 
AFRO 
central, provincial, district 
and health centres 
42 
 
Study 
Number 
Title Year of 
publication  
Country/Regional Context Disease Context and 
funder 
Operational level of 
capacity strengthening  
31 Establishing PT scheme in 
developing countries: examples 
from Africa 
2012 Africa All/ German PTB All levels 
32 CLSI: building laboratory capacity 
in Africa 
2009 Global HIV, TB, 
Malaria/PEPFAR 
All levels 
33 Public Health laboratory systems 
development in East Africa 
through training in laboratory 
management and field 
epidemiology 
2011 Africa (Kenya, Tanzania, Ghana, 
Sudan, Uganda, South Sudan) 
All infectious diseases/  
34 The operation, quality and costs 
of a district hospital laboratory 
service in Malawi 
2003 Malawi HIV, malaria, TB District level 
35 Clinical laboratory networks 
contribute to strengthening 
disease surveillance. The 
RESAOLAB project in west Africa 
2013 Mali, Burkina Faso, Senegal HIV, malaria, 
TB/French 
Development Agency 
(AFD), Fondation 
Merieux 
 
36 Improved clinical and laboratory 
skills after team based, malaria 
case management training of 
health care professionals in 
Uganda 
2012 Uganda Malaria/Accordia 
Global Health 
Foundation, IDI 
 
37 Laboratory capacity for diagnosis 
of foot and mouth disease in 
Eastern Africa: implications for 
the progressive control pathway 
2013 Eastern Africa Foot and mouth 
disease FAO/OIE 
 
38 A systematic approach to capacity 
strengthening of laboratory 
systems for control of neglected 
2014 Ghana, Kenya, Malawi, Sri Lanka NTD/DFID  
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Study 
Number 
Title Year of 
publication  
Country/Regional Context Disease Context and 
funder 
Operational level of 
capacity strengthening  
tropical diseases in Ghana, Kenya, 
Malawi and Sri Lanka 
39 Training and service in Public 
Health, Nigeria Field Epidemiology 
and Laboratory training, 2008-
2014 
2014 Nigeria All diseases/FMOH  
40 Critical role of developing national 
strategic plans as a guide to 
strengthening laboratory health 
systems in resource poor settings 
2009 Ethiopia HIV/PEPFAR, Global 
Funds, Clinton 
Foundation 
All levels 
41 Laboratory systems and services 
are critical in global health: time 
to end the neglect 
2010 Resource poor countries All diseases/PEPFAR, 
Global Funds, GHI 
All levels 
42 Country leadership and policy are 
critical factors for implementing 
laboratory accreditation in 
developing countries. A study on 
Uganda 
2010 Uganda All diseases/PEPFAR, 
Global Funds, Clinton 
Foundation 
All levels 
43 Antimicrobial resistance: capacity 
and practices among clinical 
laboratories in Kenya, 2013 
2014 Kenya all infectious diseases  
44 Strengthening Laboratory systems 
in resource limited settings 
2010    
45 Use of web based training for 
quality improvement between a 
field immunohistochemistry 
laboratory in Nigeria and its US 
based partner institution 
2013 Nigeria  primary 
46 Strategy for strengthening 
scientific capacity in developing 
2009    
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Study 
Number 
Title Year of 
publication  
Country/Regional Context Disease Context and 
funder 
Operational level of 
capacity strengthening  
countries on water and sanitation 
related issues 
47 Improvement of Tuberculosis 
Laboratory capacity on Pemba 
island, Zanzibar: a health 
cooperation project 
2012 Tanzania TB/Ivo de Carneri 
Foundation Italy 
 
46 Experience establishing 
tuberculosis laboratory capacity in 
developing country context 
2010 Lesotho WHO National level 
47 Capacity building in response to 
pandemic influenza threats: Lao 
PDR case study 
2012 Lao PDR Pandemic Influenza  
48 Medical laboratory quality and 
accreditation in Jordan 
2009 Jordan   
48 Role of Laboratories and 
Laboratory systems in effective 
tuberculosis programmes 
2007  TB  
49 Certification of TB culture and 
drug susceptibility testing 
laboratories through the revised 
National TB control programme 
(RNTCP) 
2012 India   
50 Capacity building efforts by the 
AFHSC-GEIS program 
2011 global All infectious 
diseases/USG- CDC, US 
Agency for 
International 
Development, DoD-
GEIS 
all 
51 Capacity building for zoonotic and 
foodborne diseases in the 
Mediterranean and Middle East 
2010 Mediterranean and Middle East Zoonotic diseases/  
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Study 
Number 
Title Year of 
publication  
Country/Regional Context Disease Context and 
funder 
Operational level of 
capacity strengthening  
Regions (an intersectoral 
WHO/MZCP proposed strategy) 
52 Scale up of MDRTB laboratory 
services, Peru 
2008 Peru TB  
53 ASM LabCap's contributions to 
disease surveillance and 
International health regulations 
(2005) 
2010 Botswana, China, Cote d'Ivoire, 
Guatemala, Guyana, Haiti, India, 
Kenya, Mozambique, Namibia, 
Nigeria, Rwanda, Tanzania, 
Thailand, Vietnam, Zambia, 
Zimbabwe 
Infectious 
diseases/USAID, CDC 
 
54 The WHO/PEPFAR collaboration 
to prepare an Operations Manual 
for HIV prevention, Care and 
Treatment at Primary Health 
Centres in High prevalence, 
resource constrained settings 
2009 Sub-Saharan Africa HIV/PEPFAR Primary care 
55 POPs analysis reveals issues in 
bringing laboratories in 
developing countries to a higher 
quality level 
2013 Africa (Egypt, Ghana, Kenya, Mali, 
Mauritius, Nigeria, Senegal, 
Uganda and Zambia), Central and 
South America (Barbados, Brazil, 
Chili, Cuba, Ecuador, Jamaica, 
Mexico, Peru and Uruguay), 
South Pacific (Fiji) 
POPs  
56 Laboratory capacity building in 
Asia for infectious diseases 
research: experiences from the 
South East Asia Infectious Disease 
Clinical Research Network 
(SEAICRN) 
2010 Asia (Thailand, Vietnam, 
Indonesia, Singapore) 
all infectious diseases 
(influenza in 
particular)/ NIH, NIAID, 
Wellcome Trust 
National regional 
57 The role of standards and training 
in preparing for accreditation 
2010    
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Study 
Number 
Title Year of 
publication  
Country/Regional Context Disease Context and 
funder 
Operational level of 
capacity strengthening  
58 Improving quality management 
systems of laboratories in 
developing countries 
2010 Uganda All diseases/ WHO  
59 The SLMTA programme: 
transforming the laboratory 
landscape in developing countries 
2014 Cameroon, Lesotho, 
Mozambique, Mozambique, 
Rwanda, Zimbabwe 
WHO All levels 
60 Field experience in implementing 
ISO 15189 in Kimisu, Kenya 
2010 Kenya  National 
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Annex 3: Description of interventions and their results and impact found in the literature 
 
Study 
Number 
Study Title Description of Study Results Implications/Impact/ 
Recommendations 
1 Strengthening national 
laboratories health 
systems in the Caribbean 
Region(11) 
Sensitisation meetings were held with 
MoH officials and laboratory directors. 
This was followed by a detailed 
laboratory assessment. Follow up 
assessment by PAHO 
All the countries had capacity to carry 
out smear microscopy, haematology 
testing and clinical chemistry testing. 6 
countries could perform in country HIV 
confirmation, 3 countries could roll out 
HIVRT and do viral load testing, 8 
countries conducted CD4 testing. None 
of the countries conducted DNA PCR 
testing or HIV drug resistance testing. 
Clinical laboratory monitoring was 
challenging for 6 OECS countries 
including molecular testing, viral load 
quantification (fig2).  Only 5.2% of the 
labs were accredited. All countries 
faced procurement and service 
contract challenges. None of the 
countries had government owned 
accredited lab and only 45% of the 
countries participated in EQA 
programs. Little above 20% countries 
had lab strategic plans or information 
systems 
Cumbersome process of 
testing and reporting results, 
long turnaround times, Point 
of care diagnosis was non-
existent, fewer infants 
receiving care and treatment. 
Quality assurance was weak, 
procurement challenges 
existed in all countries. There 
were several service 
interruptions leading to 
inaccurate diagnosis and 
monitoring of the patients. 
Tracking of the data was 
difficult, no standardised data 
collection or reporting of the 
results. 
2 Building laboratory 
infrastructure to support 
scale of HIV/AIDS 
treatment, care and 
function 
Multifaceted approach included 
building lab infrastructure, 
management, and laboratory personnel 
training for an effective, integrated 
tiered referral lab network, adoption of 
appropriate technologies at all levels 
and a robust QA/QC program. 
Development of 'Hub and spoke 
network model'. Hubs- tertiary care 
teaching hospitals, spokes as 
secondary hospitals, community clinics 
and health centres. Between 2005-
2008 more than 237000 patients are 
counselled and screened for HIV and 
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Study 
Number 
Study Title Description of Study Results Implications/Impact/ 
Recommendations 
referred HIV+ clients to care, 70000 for 
basic care and support for HIV and 
45000 for highly active ART regiments, 
10000 for TB screening 
3 Animal health: 
harmonisation and 
distribution of pathogen 
detection and 
differentiations tools 
workshop on harmonisation and 
distribution of pathogen detection and 
differentiation tools. Involved 
presentation of different diagnostic 
tests for various animal conditions 
1. Spain- rPCR led to rapid 
performance, sensitive, reproducible 
and reduction in risk for carry over 
contamination. 2. Pakistan- 
confirmatory testing for bacterial and 
parasitic diseases in farm animals. 
 
4 Standardisation of 
pathology laboratories in 
Pakistan: problems and 
prospects 
Narrative article The article outlines the challenges in 
standardisation of labs at international 
level. These included lack of 
pathologists (2.6 per million), 
accessibility to medical literature and 
education. Import of IMDs from 
abroad with questionable quality 
assurance. No requirements for 
revalidation, and no federal authority 
for examination and certification of 
IMDs, No ISO 15189 accreditation lab, 
costs of ISO accreditation but a 
national EQA program exists. Large 
number of small size labs competing 
with isolated large chain labs 
threatening business. 
 
5 Laboratory quality 
improvement in 
Tanzania 
1. 12 regional and district labs were 
selected as cohort for initial assessment 
.  2. Hands on activity based training 
was in three short sessions with three 
At the baseline assessment only 1 lab 
had one star which improved to 7 labs 
having one to three star scores.  
However post one year re-audit the 
scores declined for all labs who 
Personal interest and 
commitment of lab managers 
and quality officer were 
important for success. Clarity 
in the intent of accreditation 
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Study 
Number 
Study Title Description of Study Results Implications/Impact/ 
Recommendations 
month gap. 3. Re-audit was conducted 
at different intervals 
received stars, and only one star was 
received by 5/9 labs assessed. 
and workshop was important. 
Importance of a mentor was 
critical as well as conducting 
intervention in local 
language. 
6 Control and prevention 
of canine rabies: the 
need for building 
laboratory based 
surveillance capacity 
a pathway for surveillance system 
characterised by standardisation and 
decentralisation, locally based 
coordination, interpretation and 
integration of different approaches was 
suggested 
Proposed pathway for a global 
surveillance system for canine rabies 
 
7 World Health 
Organisation/HIVResNet 
drug resistance 
laboratory strategy 
narrative Developing a network of individual 
laboratories based on capacity and 
expertise to perform specific duties 
supporting WHO recommended HIVDR 
surveys. The global network is 
organised on three levels, national 
drug resistance laboratories (NDRLs), 
regional drug resistance laboratories 
(RDRLs) and global specialised drug 
resistance laboratories (SDRLs) 
 
8 Consensus and accuracy 
in haematology 
laboratories of 
developing countries: 
the Jordinian experience 
Study involved sending control 
specimens of whole blood and freshly 
prepared blood smears to 50 
laboratories each month to determine 
PCV, Hb, RBC and WBC; and blood 
smears for counting differential WBC 
count after staining 
Comparison of the re-calculated 
means of measured parameters 
between cell counter and manual 
methods showed manual methods 
gave lower mean values. The 
difference was significant for RBC and 
WBC. The percentage for Jordanian 
laboratories achieving medically useful 
analytical performance was 99% (PCV), 
97.2 (Hb), 99.5 (WBC) 
The ways in which results 
were provided, clarity and 
accuracy became better 
because of the competition 
between different labs. 
However, using all methods 
mean as target value is not 
useful in places where 
manual methods are 
dominant, as shown by this 
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study where manual method 
results were lower than that 
of RBC and WBC cell counts 
9 Rapidly building Global 
Health Security Capacity- 
Uganda Demonstration 
Project, 2013 
1. Strengthening the public health 
laboratory system by increasing the 
capacity of diagnostic and specimen 
referral networks.2. enhancing 
communication and information 
systems for outbreak response 3. 
developing public health emergency 
operating centre (EOC) 
1. Upgrading of cold-chain system for 
specimen, algorithms for 3 priority 
specimen, distribution of SOPs, posters 
and case definitions. Overall 
improvements in organisational 
management, 10 labs improved 
documentation, 3 biorisk and 
biosafety.  Overall the baseline scores 
changed from 20-36% to 34-55%. 2. 
Customised modules for each priority 
pathogen into DHIS-2. 3. SMS 
notification and feedback for samples, 
sample tracking alerts. 
3 areas of focus for efficient 
and sustainable approach to 
enhance capacity building 
were identified- detection of 
health threats through 
laboratory and other 
systems, coordination of 
information and response 
through EOCs and prevention 
of avoidable threats. A need 
for holistic approach involved 
these three areas.  Expansion 
of the system to other 
pathogens including Zika, Hep 
E et. 
10 Rehabilitating public 
health infrastructure in 
post conflict setting: 
epidemic prevention and 
preparedness in Kosovo 
1. Extensive consultations conducted 
between WHO, IPH, UNHCR  to develop 
a program design, with WHO as lead 
agency to provide technical support. 2 
WHO as lead agency coordinating with 
IRC to develop 6 focussed interventions 
The interventions included: 1. Kosovo 
Health surveys-violent trauma main 
reason for 64% of deaths, vaccination 
coverage rate for children under 5 
<20%, management of diarrheal 
diseases poor. 2% of the mobile 
accessed mobile health clinics run by 
NGOs. 2. Standardised case definitions 
and case-management protocols-
clinical case management protocols 
were developed for 14 infectious 
diseases and distributed to health 
professional, primary care and poly 
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clinics, and clinical epidemiologists. 3. 
Public Health Surveillance system- 
Infectious diseases surveillance and 
response commission comprising of 
epidemiologists, microbiologists, 
public health managers from WHO, IRC 
and IPH was formed; with data analysis 
and interpretation at 6 regional IPH 
offices coordinated by central IPH 
office in Pristina. Training of IPH staff 
on surveillance systems, and national 
wide training of primary care clinicians 
on case definitions and surveillance 
forms. 4. Rehabilitation of 
Microbiology Laboratories- significant 
deficiencies in staffing, equipment and 
supplies were found in seven 
laboratories that were assessed. 
Training was provided for 
microbiological testing, and priority 
equipment and supplies were provided 
. 5 Establishment of community based 
public health education and promotion 
campaign-Commission for health 
promotion was established with 
representatives from WHO, IPH and 
NGOs who developed policies and 
protocols for community outreach 
with focus on media campaign on 
HIV/AIDS, STIs, safe motherhood, 
violence against women. 6.  
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Development of epidemic response 
capacity- 5 epidemic response teams 
(each with 4-5 members) were 
established at regional offices, 
workshop on epidemic preparedness 
and response was also organised. 
11 Strengthening 
tuberculosis diagnosis in 
a low-resource setting: 
experience learned in 
Dodoma, Tanzania 
1. Restructuring of the Tuberculosis 
section and separating it from the main 
lab. 2. Purchase of new equipment for 
implementing TB microscopy and 
culture. 3 Personnel training to improve 
quality of TB diagnosis, introduction of 
sputum microscopy, TB culture and 
external EQA. 
1. Three laboratory personnel were 
trained in TB diagnosis and biosafety 
procedures who further trained other 
DRH personnel. 2. Implementation of 
sputum smear microscopy led to an 
increase in reporting of TB cases from 
11.2% in 2009 to 14.2% in 2010. 3. 
Introduction of TB cultures increased 
the positive confirmatory drug 
susceptibility testing. 4. DRH 
coordinated EQA was conducted for 10 
peripheral labs. 
Cooperation program led to 
an increase in the number of 
samples and case detection 
rates 
16 Non traditional security 
and infectious diseases 
in ASEAN: going beyond 
the rhetoric of 
securitisation to deeper 
institutionalisation 
narrative A. WHO and ASEAN funded networks 
include. 1.Deploying resources for 
national and regional laboratories for 
speedy diagnosis of cases of human 
infection and stockpiling of drug and 
vaccines.2. Developing website of 
ASEAN-Disease Surveillance Network. 
3. Development og ASEAN Plus Three 
(APT) framework. 4. Establishment of 
APT Emerging Infectious Diseases (EID) 
Program. 5. Development of East Asian 
Summit (EAS) and EAS Declaration on 
Avian Influenza Prevention, Control 
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and Response. B. US-Funded REDI 
network for tracking, controlling and 
researching emerging infections. 
17 Building public health 
capacity in Afghanistan 
to implement the 
international health 
regulations: a role of 
security forces 
1. FETP- training program for two 
years.2 DEWS- syndromic surveillance 
system. 3. PRT- clinic construction, 
medical training, purchase of medical 
equipment and text books, patient care. 
  
18 Strengthening public 
laboratory service in 
sub-Saharan Africa: 
Uganda case study 
narrative Capacity building pyramid is suggested 
utilising the resources from existing 
programs such as PEPFAR and SLMTA. 
This pyramid refers to a stepwise 
process leading to getting WHO-AFRO 
accreditation based on SLMTA. 
 
19 Capacity building of 
public health 
laboratories in 
Afghanistan: challenges 
and successes 
1. Needs assessment was carried out 
with focus on human capital, 
infrastructure, management and 
training. . 2. Establishment of disease 
warning system sharing surveillance 
data with WHO, FAO, USAID. This also 
included lab based disease surveillance 
and research. 3. CPHL reserved as 
national reference lab for outbreak 
reports. 4. Training of laboratory staff 
1.After needs assessment space 
remodelling and renovations were 
done in CPHL to accommodate new 
equipment for diagnostics. Upgrading 
of provincial hospitals to conduct 
bacterial culture and serology.2. 300 
laboratory sessions for 140 trainees at 
different sites. 76 days of internal 
training for 236 Afghan health care 
professionals using NAMRU-3 
materials. 40 technicians, 4 field 
epidemiologists and 10 support staff 
were recruited to train exclusively 
under NAMRU-3 to perform diagnostic 
procedures following SOPs. 3.Disease 
early warning system sites increased 
Fulfilling of WHO IHR 
regulations by Afghanistan 
through huge leap in 
monitoring the burden of 
infectious diseases. Improved 
vaccination programs, 
decrease in mortality rates 
for young children from 
257/1000 in 2002 to 
191/1000 in 2008. Increase in 
life expectancy from 42 to 61 
years 
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from 123 in 2007 to 344 by 2013. 4. 
CPHL recognised by WHO as Afghan 
national influenza centre given the 
expanded capacity for pandemic flu. 
Improved diagnostic capacity in CPHL 
for other illnesses such as acute febrile 
illness, water diarrhoea and vector 
borne disease. 
20 Building laboratory 
capacity to support the 
global rotavirus 
surveillance network 
supporting surveillance activities 
including sentinel site hospital selection, 
specimen and data flow management, 
lab performance monitoring and 
regional meeting planning. 
107 sentinel hospital laboratories, 36 
national laboratories, 9 regional 
reference labs, one global reference 
lab has been established. Sentinel 
sites- enrol children<5 yrs hospitalised 
with acute gastroenteritis and confirm, 
presence of rotavirus in stool. National 
labs- testing, specimen storage, 
selection and distribution of positive 
specimen for genotyping. Rotavirus 
regional labs (RRL)- bulk genotyping. 
Global reference lab- technical support 
to RRL, training, QA, QC, provision of 
reagents and procedures. 
1.Establishment of a rotavirus 
laboratory technical working 
group in 2012 to increase 
standardisation of methods 
and procedures. 
Standardisation in genotyping 
data collection, developing 
SOP for sample handling, 
storage and shipping; routine 
confirmation of subset of 
genotypes. 2. Number of 
reporting countries increased 
from 44 (2008) to 64 (2011), 
sentinel hospitals from 132 to 
185. Number of children 
enrolled- 41414 to 48947, 
detection rates from 36% to 
41%,  5 globally prevalent 
genotypes identified, 
21 Expansion of global 
measles and rubella 
laboratory network 
2005-2009 
Network consisting of subnational level 
to global reference laboratory for 
surveillance of measles and rubella, in 
each WHO region. The network has 
1. By 2010- 690 labs attached to the 
network which follow standardised set 
of testing protocols, reporting 
procedures and strong focus on QA. 
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focus on testing strategies, quality 
assurance and surveillance indicator, 
coordination and integration. 
National level-162, regional reference 
19, global 3 and sub national 506. 2 
Two to three regional labs selected in 
each region as centre for excellence. 4. 
Comprehensive evaluation of sampling 
techniques using IgM detection, viral 
RNA detection, sequencing molecular 
surveillance, temperature stability and 
ease of use. 5. 220 laboratories 
globally participating in proficiency 
testing program at all levels. 5. 
Laboratories expanded detection and 
surveillance into yellow fever in central 
and western africa (23), Japanese 
encephalitis in SEAR (13), WPR (9), HPV 
(10). 173,000 test conducted for 
measles in 2009. 
22 Assisting cytopathology 
training in medically 
under-resourced 
countries 
Suggestions are made for different ways 
of training cytopathologists to use FNB 
for diagnosis. These include-internet 
based distance learning courses, series 
of cytology tutorials run in-country by 
international experts periodically, 
Sandwich fellowships in the UK for 
medical trainees. telepathology for 
primary reporting or second opinions, 
shipping specimen 
Between 2007-2010 a series of in 
country cytology tutorials were 
organised, conducted by western 
experts. Uganda- 2, Nigeria-2, Kenya-3, 
Tanzania-2, Ibadan-1, South Africa-1 
 
23 Impact of international 
laboratory partnerships 
on the performance of 
HIV/sexually transmitted 
Pilot Ethnographic study was conducted 
in each country to identify high risk 
populations, specific venues they are 
located and identified popular opinion 
The initial trial was conducted to find 
vulnerable population and social 
congregating points and collect 
samples for QC/QA 
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infection testing in five 
resource-constrained 
countries 
leaders. 2. Post pilot study trial was 
implemented- in-depth risk behaviour 
assessment interviews at baseline at 12 
months and 24 months involving 40-188 
participants in each 20-40 community 
venues per country. 18147 participants 
recruited in 138 venues in 5 countries 
and 54438 specimen collected over 3 
time points 
24 Impact of international 
laboratory partnerships 
on the performance of 
HIV/sexually transmitted 
infection testing in five 
resource-constrained 
countries 
Post pilot study QC/QA was carried out 
with three major components. 1. 
personnel training of lab personnel 
before the trial and during the trial, on-
site training 2. Manuals for the multi-
country study. 3. ongoing QA 
monitoring of study procedures. For 
these 2 new labs were constructed in 
India and Russia, upgrading of two labs 
in China and Zimbabwe and use of US 
Military lab in Peru 
1. Training- 2nd training of lab 
managers had 100% results syphilis 
and trichomonas testing. 3 sites- 100% 
correct HIV EIA and WB testing. Two 
sites participating in CT/NG testing had 
100% results. Proficiency panel results 
for in-country labs-majority of the 
countries had between 85 to 100% 
results in panel testing for 7 diseases. 
Reference lab QA- 80-100% results 
were achieved. There was a 
continuous progression of the QA in 
the countries over the years of training 
and monitoring. 
 
25 The World Health 
Organisation African 
Regional Laboratory 
Accreditation Process 
The WHO step wise accreditation 
process is designed to address the gap 
between the requirements of ISO15189 
and current status of labs in Africa. A 
systematic effective quality 
management system for lab testing, 
strong QA, QC and QI including pre-
analytical and post analytical processes. 
The key building blocks of 
accreditation process include 1. 
Standards and assessment tools- based 
on ISO15189:2007 (E) with 12 
categorical sections for assessment on 
the basis of 110 clauses and 250 
points. 2 Assessor and assessor 
training- drawn from labs in Africa, the 
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assessors will be trained in Kenya 
(English speaking) and Cameroon 
(French speaking) but cannot assess 
their own country labs and not 
financially compensated.3. Equipment 
calibration and biosafety- work with 
Field Epidemiology Network Lab in 
Uganda for training. 4. Laboratory 
Management training and Mentoring- 
Development of SMLTA which after 
initial assessment provides a series of 
training sessions to build national 
training teams for SMLTA in 12 
countries for labs till facility level. 5. 
Proficiency testing- Dept of 
Bacteriology and Virology of Dantec 
Hospital, Dakar, Digital PT, National 
Institute for communicable diseases, 
national health lab services South 
Africa will provide PT for several 
diseases using serology, microbiology, 
chemistry, haematology and 
parasitological testing. 
26 Building laboratory 
capacity to support HIV 
care in Nigeria: 
Harvard/APIN PEPFAR, 
2004-2012 
1. A three level primary, secondary, 
tertiary network of laboratories was 
organised and linked for HIV testing and 
diagnosis. Primary care-rapid testing, 
blood samples. Secondary level-
serology, CD4+, haematology, clinical 
chemistry setting. Storage for VL, DBS. 
Tertiary level-large HIV ART programs at 
1. 35 laboratories were developed in 
total. 18 major sites managed (8 
tertiary and 10 secondary level labs). 7 
labs designated as Centre of Excellence 
by Nigerian Ministry of Health. 2. All 
secondary and tertiary labs also had 
capacity for TB diagnosis, treatment 
and care, and two for MDR TB testing 
1. Significant impact was seen 
on overall health system 
strengthening through a 
variety of approaches 
including training of the 
trainers, utilising centralised 
training conferences for 
assurance of standardisation 
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university associated hospitals. 2. Clinic 
selection after detail assessment from 
site visit, followed by needs assessment. 
3. Standardisation in equipment 
procurement and training. Lab 
modifications for effective logical 
sample flow and processing, supply 
chain for test kits with two warehouses 
for distribution. 3 Trained on-site 
engineers (varying expertise) for 
equipment maintenance. 4. Electronic 
medical records system for data 
management linked by local computer 
networks for easy flow of information 
within each site. 5. Tertiary labs to 
provide trainings to staff at secondary 
and primary level. 
and using this for national TB control 
program. 3. Harvard/APIN PEPFAR 
supported labs conducted over 2.5 
million tests and results for HIV from 
2004-2012. EID testing expanded 10 
fold from 2007 to 2008 with over 9000 
HIV exposed infants tested. From 2009 
testing was completely taken over by 
APIN 
and network exercise. 2. 
Electronic data management 
led to decrease in the 
transcription errors, 
turnaround time, aggregate 
reporting at national level, 
development of treatment 
response utility system for 
comprehensive picture of 
treatment profile of 
individual patient and help in 
clinical decision making. 3. 
Harvard/PEPFAR labs 
subscribed to EQA and 6 labs 
were included in SMLTA roll 
out in 2010, with one lab 
achieving 5 star, five 4 stars. 
27 Building capacity for the 
assessment of HIV drug 
resistance: experiences 
from the pharmaccess 
African studies to 
evaluate resistance 
network. 
A network of 6 countries in Africa was 
developed with specific focus on HIVDR 
surveillance through population level 
assessment forHIV1 DR and patient 
follow up during 1 and 2 line ART 
(PASER Monitoring/PASER M). The 
chosen sites were given laboratory 
training in GLP, Good Molecular 
diagnostic Practices, sample handling 
and documentation using web based 
specimen track and trace system. A 
limited number of central reference 
labs were chosen for testing and 
ensuring standardisation and quality 
During the 5 annual networking 
meetings 100 clinicians and 86 labs 
received training. PASER-M achieved 
96% (n=3007) patient recruitment with 
82% retained in the 12 months follow 
up. 
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assurance. More than 2 EQA were done 
and PT was carried out before 
genotyping. 2. Central web based 
ViroScore Suite Database was used for 
all data sequences for storage and 
quality control. 3 To mitigate expensive 
costs of genotyping- a private public 
consortium ART-A was developed for 
novel, simple diagnostic technology for 
HIV viral load testing, detecting and 
interpretation of HIVDR in clinics and 
labs. 3. Regular monitoring visits to sites 
were conducted that also included 
teaching and training of basic research 
skills to investigators, clinicians, nurses, 
lab technicians. Also followed by annual 
network meetings. 
28 Surveillance of 
antimicrobial resistance 
in resource-constricted 
settings- experience 
from five pilot projects 
1. Three site in India (Delhi, Mumbai, 
Vellore) and two in South Africa (Brits, 
Durban) were chosen for study. All in 
urban areas attached to big hospitals, 
and Vellore also had access to rural 
settings. 2 Each site was given a 
framework protocol to collect 
community based AMR data every 
month for 12 months with one or two 
bacteria as indicators.3. E.Coli was used 
an indicator at 4 sites (3 India, I South 
Africa)  and faecal from patients, urine 
was collected from pregnant women. 
The antibiotics tested included 
High resistance rates were found in all 
sites, and in Vellore no difference in 
settings was found between urban and 
rural populations. In Mumbai, the pre- 
and post-antibiotic use in the samples 
did not vary significantly between 
groups. In Mumbai, Brits and Durban 
where samples were collected from 
different facilities, no difference was 
found in resistance rates. Data from 
two sites that distinguished 
commensals from pathogens showed 
higher AMR rates among  E. Coli 
causing UTI for all antibiotics tested. 
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ampicillin, cotrimoxazole, 
chloramphenicol, nalidixic acid, 
ciprofloxacin. In South Africa, S. 
Pneumonia and H. Influenzae were 
obtained from sputa of the patients and 
ampiclin, cotrimoxazole, 
chloramphenicol, and erythromycin. 4. 
Resistance was tested only for ABMs 
commonly used for treatment of 
infections in the community. 
29 WHO global Salm-Surv 
external quality 
assurance system for 
serotyping of salmonella 
isolates from 2000 to 
2007 
narrative In 2000 WHO established Global Salm-
Surv  EQAS to enhance lab based 
surveillance of salmonella infections 
and other food borne diseases through 
enhanced serotyping of Salmonella 
species. 2. Assessment of laboratory 
capacities for correctly serotyping by 
shipping 8  blinded salmonella isolates 
to labs. Submission of results to EQAS 
web based reporting system with 
secured individual passcode .3. Results 
are given as a report itemizing errors 
relative to the expected results and 
can be used by participants to evaluate 
accuracy of current techniques and 
quality of anti-sera in labs 
 
30 WHO global Salm-Surv 
external quality 
assurance system for 
serotyping of salmonella 
8 Salmonella strains were selected for 
each EQAS iteration. Except the strain 
for Salmonella serovar Enteritidis, all 
other strains were included once only in 
EQAS iterations in 2000, 01, 04, 06, 07. 
1. 249 labs in 97 countries participated 
in EQAS from 2000 to 2007. 44labs/35 
countries in 2000, 96labs/55countries 
in 2001, 99 labs/61 countries in 2002, 
127labs/72countries in 2003, 127 
Important regional 
differences in serotyping 
results for Salmonella 
species. 
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isolates from 2000 to 
2007 
Testing instructions with participating 
laboratory record sheet on CD with 
Salmonella Agar stab cultures were sent 
to participating countries under IATA 
regulations. Results were submitted 
either online via secure site or fax or 
email. 
labs/71 countries in 2004, 
130labs/66countries in 2006, 140 
labs/68 countries in 2007 participated. 
2. The average number of labs per 
EQAS iteration between 2000-07 was 
102. 3. 125 labs participated in 3 tp 4 
iterations and 92 in four or more.4. 
54% to 92% labs performed serotyping 
on all 8 strains. 5. The percentage of 
correct serotyping was 76% (2000), 
72%(2001), 91% (2002), 80% (2003), 
88% (2007). Reporting of zero errors 
increased from 48% in 2000 to 68% in 
2007. 6. The rate of errors ranged from 
41% in 2006 to 3.6% in 2007 
31 Developing laboratory 
systems and 
infrastructure for HIV 
scale up: a tool for 
health systems 
strengthening in 
resource limited settings 
Role of PEPFAR 1 and 2 in strengthening 
laboratory systems for HIV scale up is 
described. The areas include 1. Human 
capacity development 2 infrastructure 
and logistics and supply chain 
management and development. 3. 
Quality assurance. 4. laboratory data 
collection and indicators. 5 
harmonisation 
Examples included 1. Human capacity 
development-African Centre for 
Integrated Laboratory Training in 
Jo'burg South Africa to provide south 
to south training. 2. Performance 
based financing in Rwanda for staff 
retention, pay increase for pharmacists 
in Botswana. 3. Infrastructure- 
National Laboratory Strategic Plan for 
Ethiopian Health and Nutrition 
Research Institute (EHNRI) where 
national reference lab, 4 regional 
hospitals, 6 regional labs are 
renovated. Rwanda 'common basket' 
for implementing partners to 
contribute and national central 
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purchasing unit (CAMERWA). Supply 
issues in cold chain addressed by 
propane powered refrigerators in 
Nigeria.5. Quality Assurance- APIN 
conducts QA in Nigeria, National 
Institute of Medical Research in 
Nigeria is ISO certified. 6. Laboratory 
data collection and indicators- PEPFAR 
2 and ICAP as tools for assessment. 7 
Harmonisation- EHNRI Ethiopia 
oversees all standardisation process in 
the country working with US SCMS for 
procurement and maintenance of 
equipment. 
32 Strengthening systems 
for communicable 
disease surveillance: 
creating laboratory 
network in Rwanda 
EQAS was conducted by WHO-AFRO, US 
CDC for Rwanda to assess national lab 
network 
1. Surveillance- After ISDR 
implementation in 2001, disease 
priorities were streamlined with 19 
high priority diseases, staff training 
provided in testing, management 
through a series of workshops. 2. NRL 
is autonomous with diagnostic 
capacities for HIV, TB, Malaria, 
influenza, H5N1. Decentralisation of 
administrative function of NRL to 
expand capacity, management and use 
of surveillance at all levels, GIS use, 
bacteriology labs set up in 5 district 
hospitals. 3. Coordination and function 
of lab network. NRL equipped with 
PCR, flourance activated cell sorting, 
lymphocyte %age for infants. 4 
Improvements in strain 
isolations by NRL. For 
Cholera- from 46 specimen 
(2005), 17 (2006), 110 (2007). 
Dysentry-11 (2005), none 
(2006), 110 (2007) Measles 
188 (2005), 187 (2006), 132 
(2007). Typhoid 42 (2006), 44 
(2006), 132 (2007). 
Meningitis 20 (2005), 21 
(2006), 22 (2007). The 
number of VCT sites 285 in 
2007. QC results showed 
improved discordance rates 
to 0.8% in 2008. The QC for 
TB slide examination- 
increase from to 60 (2003) to 
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reference labs and NRL connected to 
34 district hospital labs and 385 health 
centre labs at peripheral. Each with 
defined SOPs. 126 health centres with 
HIVRDT and expansion of PMTCT. 5. 
Training- 467 biotechnologists on lab 
detection of malaria, HIV rapid testing, 
SLP and biosafety in 2005. 969 lab 
personnel trained in integrated lab 
training in Malaria, TB, HIV, 
biochemistry and haematology (61 
participants), CD4 counts (34 
participants), dried blood spots (180), 
HIV specific testing at new VCT sites 
(223). 6 Supervision- 420 labs get 
assessment every year some more 
than once. 517 (2005), 862 (2006), 689 
(2007). 7. External collaboration is 
maintained with each partner by 
allocating specific facilities to avoid 
duplication. Establishment of TRAC 
allows integrated clinical planning and 
lab activities. National disease 
programs integrated with external lab 
ref systems such as Polio, measles 
(WHO AFRO and UVRI), MDRTB with 
IMTA Belgium for QC testing. QC 
panels for epidemic bacteria, malaria, 
TB microscopy, CD4 counts, ELISA and 
western blot received for NIPH South 
Africa. 
183 (2007) CDT sites 
participating in QC. 
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33 Capacity building and 
predictors of success for 
HIV1 drug resistance 
testing in the Asia-Pacific 
Region and Africa 
the intervention involved proficiency 
testing in genotyping by distributing 
nine 5-sample TAQAS panels (45 
samples) to 19 labs in 11 Asian 
countries and 2 African countries for 
testing using their standard protocols. 
Samples were sent biannually from NRL 
Australia and results were returned to 
NRL Australia. This was followed by a 
detailed protocol questionnaire to 
participating labs on testing methods. 
1. Eight laboratories reported results 
of all nine panels. 2 Questionnaire was 
completed by all but one lab 
demonstrating a wide variability in 
genotyping experiences. The average 
length of labs conducting genotyping 
testing was six years, 348 tests per 
year, sample turnaround time was 14 
days. 2. Majority of the labs (18/22) 
used locally assembled protcols.3.  
fourteen 4. labs required bachelor's 
degree qualifications or higher. 5. Only 
6/22 outsourced sequencing. 6. Most 
20/22 used an automatic base calling 
software and all reported manual 
checking and editing of automated 
base calls. 7. The peak height to call 
mixed bases was set at 20-30% by 19 
labs. 8. Most labs (15/22) labs 
reviewed sequenced data at sites 
associated with ARV resistance. 9. 
Fifteen used Stanford Database for 
resistance interpretation in other three 
used IAS-USA or ANRS along with 
Stanford database. 10. A total of 144 
data sets were returned by 23 
participating labs, with 10 labs 
returning results up to five weeks past 
the turnaround time. 136 datasets 
were suitable for assessment. The 
median detection of DRMs in TGs in 7 
HIVDR genotyping was 
associated with the panel 
complexity and with lab 
performance factors such as 
detection of mixtures and 
agreement with TG but not 
with differences in the lab 
use of commercial vs in-
house tests or sequencing 
protocols 
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plasma panels ranged between 88 to 
98%. Three labs detected <80% initially 
but subsequently improved. 
34 Evidence-based 
approach to the 
maintenance of 
laboratory and medical 
equipment in resource 
poor settings 
1. between 2003-2008, approx 100 
engineering students, biomed 
technicians and engineers (volunteers) 
gathered data on out of service medical 
equipment from 60 resource poor 
hospitals in 11 countries. The hospitals 
were of varied size, limited technical 
staff, and tech staff not qualified in 
BMET's in 11 countries. 2. It was 
followed by analysis of out of service 
equipment and repairs were attempted 
by volunteers using local spare parts 
(purchased or repaired), using basic 
repair tool kit and advice from expert 
engineers. Volunteers were not allowed 
to purchase or order parts from outside 
the country.3. Every piece was labelled 
repaired (only if returned for use) or not 
repaired (included repaired but still not 
used upon return). 4. Detailed reports 
were filled by volunteers on each 
equipment and reanalysed by second 
engineering student, and selected cases 
by experienced and licenced engineers. 
Total of 2849 engineering requests 
were analysed. Of those 2529 were 
medical equipment, 320 non medical 
equipment. 1821 were repaired and 
made in use (72%). 2. The type of 
devices included blood pressure 
devices (294), nebulisers (123), pulse 
oximeters (104), ECG (86), incubators 
(80), electro-surgery devices (77), 
infusion pumps (77), autoclaves (74), 
microscopes (65), centrifuges (63), X 
ray devices (57), ventilators (57). 3. 
The six domains of knowledge required 
from documentation included- 
electrical, mechanical, power supply, 
plumbing, motors and installations or 
user training. A further 26 
units/concepts/skills were identified in 
6 domains needed for diagnosing the 
problem and executing repair. Within 
26 units 107 further skills were 
documented in more than one repair 
in a basic unit.  4. of total 1704 
documented, repaired pieces 1132 
(66%) were put back in service using 
one of the 107 skills identified and 
using local spare parts. 
The results show that medical 
equipment repair do not 
require major import of spare 
parts to be returned to 
service upon repair. Lengthy 
post-secondary training for 
licences and engineering is 
not suitable for resource 
poor settings. 
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35 Impact of horizontal 
approach in vertical 
program: continuous 
quality improvement of 
malaria and TB 
diagnostic services at 
primary level medical 
hospitals in the context 
of HIV care and 
treatment program in 
Ethiopia 
1. Laboratory Quality Improvement 
tools were developed to assess and 
monitor the quality of both malaria and 
AFB microscopy total testing process. 
The tools comprised of 100 closed 
ended questions divided into 12 
sections with containing general and 
specific aspects.2. LQITs used in 5 
Health Centres and one faith based 
hospital labs in Showa zone of Oromia 
region. 3 Data collected quarterly at 
baseline at all 6 sites 
1. Baseline scores for MALScore were 
between 42 to 61% for all labs (all labs 
were unsatisfactory). Similarly AFB 
Score was between 41 to 70%. (one 
Health centre was satisfatory). 2 
Monthly follow up, onsite training and 
mentorship, documentation and 
quality assurance support provided 
help with improving lab services.2. 20 
lab professionals received onsite 
training to address the gaps seen ins 
LQIT assessment. 3 At the end of 6th 
quarterly assessment the MalScore 
was between 88-90% and AFBScore 
between 88-95%. 4. The Human 
resources issued showed constant 
increases due to identification of focal 
persons for malaria and AFB 
microscopy and regular refresher 
training. 5. Safety- MalScore was 100% 
at baseline, AFBScore improved from 
67 to 82% with a development of TB 
infectious waste disposal protocol. 6.  
Regular improvements seen in lab 
process- slide prep, staining, 
maintenance, microscope, reading 
reporting of results. This was because 
of implementing SOP during 3rd and 
4th quarter and poster display for 
WHO malaria staining process. . 7 
Improvements in documentation of 
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quality procedures into routine 
activities 8. Quality control section 
scored the lowest at baseline but 
showed improvement in quarter 4 due 
to introduction in SOP for malaria and 
AFB quantifications 
36 Implementation of 
quality system approach 
for laboratory practice in 
resource-constrained 
countries 
narrative 1. Needs assessment is carried out by 
GAP team in the country at the 
invitation of the government including 
review of the proposed country plan. 2 
Seeking commitment from 
governments for strengthening lab 
program 's capability and capacity, 
followed by assessment of current lab 
practices at all levels to identify gaps 
and enable priorities.3. Big meeting of 
all laboratorians together to begin 
establishment of a national system of 
labs, national approach to QA, and 
better communication, training needs. 
 
37 Working towards a 
sustainable laboratory 
quality improvement 
programme through 
country ownership: 
Mozambique's SMLTA 
story 
1.In 2011 national lab technical working 
group (TWG) consisting of MoH 
personnel, partners were established to 
build framework for National lab quality 
improvement program.2. The TWG 
developed SLMTA implementation plan 
which included training, mentorship, 
supervision and audits; with dedicated 
coordinator and SLIPTA focal person. 3. 
Training toolkit was translated into 
Portuguese and locally relevant 
1. All eight labs completed three 
SLMTA workshops, 6 had complete exit 
audit data, 2 had missing data or 
excluded from analysis. Overall 
improvement was seen in all 6 labs 
after 12 months of implementation- 
three labs (1 star), one lab (2 star), one 
lab (3 star). 2 The greatest areas of 
improvement were client 
management, customer service, 
corrective action, purchasing and 
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implementation strategies were 
developed and local Portuguese 
FOGELA was created for this program. 
4. This was implemented in phases and 
hierarchical approach with top-tier labs 
(NRL and central hospital labs) first 
enrolled. Post-training, the trained 
personnel became resource person for 
training, mentoring and supervising 
others. 5. Training was also given to 15 
auditors using WHO-AFRO Auditor 
training curriculum. 6. 2011- new 
auditors with experienced auditors 
carried out baseline audits for the eight 
enrolled labs based on SLIPTA checklist 
inventory, and management reviews. 
The areas of least improvement were 
information management, equipment, 
facilities, safety, internal audit. 3. The 
National TB Ref Lab  was best 
performing with 3 stars. 4. At the end 
of the program 3 labs officially 
enrolled into SLIPTA program for 
review by auditors from ASLM. 
38 Establishing PT scheme 
in developing countries: 
examples from Africa 
1. In country PT schemes for food and 
water testing were organised and 
training of the personnel in SADC and 
EAC countries in Africa. 2. three samples 
for water PT schemes and two in food 
PT were distributed for same 
measurands. 3. Assessment was made 
using Z scores. 
1. Number of participants from 18 
African countries participating in PT 
scheme for microbiological analysis of 
water- 23 (2008), 9 (2009), 33 (2010), 
40 (2011). 2. Number of participants 
from 20 African countries participating 
in PT scheme for chemical analysis of 
water- 39 (2006), 47 (2007), 45 (2008), 
54 (2009), 58 (2010), 54 (2011). 3. The 
data showed chemical analysis of 
water being outside the acceptable 
range in three samples. T 
The use of low cost methods 
for analysis of the 
measurands is one factor for 
lack of insufficient quality of 
the participants results and 
corrective actions taken after 
failing in PT rounds. 
39 CLSI: building laboratory 
capacity in Africa 
narrative 1. Two pronged approach is taken for 
capacity strengthening: LS 
strengthening and GHP. It supports 
individual countries and also national 
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lab systems through standard 
development activities for its 
members. 2. Initial site visit for 
measuring existing capacity, is 
followed by needs assessment for 
identifying gaps and design a 
customised training program for best 
practices. 3. Implementation of 
selected improvements done through 
Mentor/Twinning program for 3 
months where experts work with local 
lab professionals to facilitate 
improvement strategies and prepare 
for accreditation, including self-
assessment tools. 4. Each year two in-
country lab leaders are given 
sponsorship to attend annual CLSI 
leadership conference. 
40 Public Health laboratory 
systems development in 
East Africa through 
training in laboratory 
management and field 
epidemiology 
25% of classroom instructions and 75% 
field assignments. The lab residents 
take course on epidemiology, bio stats, 
research methods, scientific 
communication, public health 
surveillance, computers in public health, 
lab methods in field, lab management 
and leadership 
  
41 Measuring laboratory 
based influenza 
surveillance capacity: 
development of the 
1. PHLs, CDC and SMEs in influenza 
collectively developed a tool to assist in 
assessing international lab capacities for 
testing influenza specimen and quality 
control management.  The tool 
The tool was tested by SMEs and 
revised to add quantitative framework. 
The validation of the quantitative 
framework was done retrospectively. 
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international laboratory 
capacity review tool 
represented essential lab functions and 
practices of WHO NICs. The tool was 
organised in 9 categories containing 
questions to evaluate lab practices, 
identify strengths and develop 
recommendations. 37 assessments 
were done between 2009-11. 2. The 
tool contains 271 questions that fall into 
informational category or capacity 
related (180), an equipment table and 
training table. 2. 164/180 questions 
were used for quantitative analysis. 164 
questions divided into 8 categories for 
analysis in capacity. 
 
 
42 The operation, quality 
and costs of a district 
hospital laboratory 
service in Malawi 
A survey was carried out in Ntcheu 
district hospital to collect baseline data 
on the operation, quality and costs of 
the current district laboratory services 
in Malawi as a basis for the 
development of essential laboratory 
package. Data was collected on tests, 
workload and staffing levels; quantity 
and type of consumables required, 
inventory of equipment, quality of tests 
(cross testing at SSI Denmark and LSTM 
UK) for TB microscopy and malaria 
microscopy, haemoglobin measurement 
and  blood transfusion for grouping and 
compatibility tests; economic costings 
1. Tests, workload and staffing- 31203 
tests were performed between 1997-
98 (malaria microscopy-21%, TB 23%, 
Hb 13%, transfusion 26%). Average 
technician worked for 23.8 hrs/week 
comprising 2479 hrs/year against the 
required 3970 hrs for the work.2 All 
tests were carried out in the same 
room with poor ventilation and no 
safety cabinets, no autoclave or 
appropriate disposal of waste, cleaning 
and washing procedures for the lab 
were inconsistent.3. Quality of tests: 
Except Hb testing, the concordance 
between the test results and reference 
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for resources used in the different tests, 
human resources costs. 
result was over 90%, for Hb it was only 
37% (combined failure of all types of 
transfusion). 4.  The economic costs of 
lab for one year of study was US$ 
32618, TB microscopy US$13547, 
transfusion and Hb measurement US$ 
11 207,  malaria $2708. 
43 Clinical laboratory 
networks contribute to 
strengthening disease 
surveillance. The 
RESAOLAB project in 
west Africa 
RESAOLAB was established with support 
from AFD and Fondation Merieux. The 
three key areas of activity include 
training laboratory personnel, setting 
QA, strengthening epidemiological 
surveillance 
1. Training- a shared national strategic 
plan for continuous education of lab 
technicians was developed containing 
9 modules. Till 2013 64 sessions with 
25 participants in each have been 
conducted. Also available for self-
training via GLOBE. 2. Setting quality 
assurance-  shared national strategic 
plan for lab quality management was 
developed to define standards for 
personnel organisation, lab 
equipment, procedures, data 
processing, hygiene and security. Also 
identified 4 labs in each country for 
EQA. Till 2013, 350 supervised EQA 
conducted. 3. Strengthening the 
epidemiological surveillance- open 
source lab information and 
management system was developed 
for monitoring daily surveillance 
activity. Training workshop on how to 
use new tool was conducted in 
collaboration with WHO-AFRO. 
RESAOLAB played key role 
during cholera outbreak in 
Mali in 2011. Other countries 
in region- Niger, Togo, Benin, 
Guinea have made requests 
to join RESAOLAB> 
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44 Improved clinical and 
laboratory skills after 
team based, malaria 
case management 
training of health care 
professionals in Uganda 
Integrated management of Malaria, 6 
day course was organised at 8 sentinel 
sites by JUMP. It included didactic and 
practical sessions, and participants 
included clinicians, lab professionals, 
health info assistants. A baseline 
observation of clinical care and lab 
testing was done prior to training. 2. 
Three support supervision visits were 
conducted by JUMP team at approx 6 
weeks, 12 weeks, one year post 
workshop to give feedback and perform 
onsite observation. 3. The evaluation 
involved the assessment of clinical skills 
and laboratory skills. 
1. 118 clinicians were trained, 101 
observed (61 at baseline and once 
after training).2. Performance of 5 key 
skills for patients presenting with fever 
improved between baseline and three 
follow up visits. 3. History taking for 
children < 5yrs and patient education 
for >5 yrs did not improve much in the 
one year follow up.4. Preparation of 
malaria smear improved significantly  
from baseline in each follow up visits. 
The sensitivity of interpreting smear 
results increased significantly (84%), 
specificity also increased (91%) (WHO 
standard was met for specificity (90%) 
but not for sensitivity).  However, it 
was not possible to distinguish effects 
of JUMP from UMSP as they were 
jointly implemented at the same sites. 
 
45 Laboratory capacity for 
diagnosis of  foot and 
mouth disease in Eastern 
Africa: implications for 
the progressive control 
pathway 
1. Cross sectional prospective survey 
was conducted to assess the lab 
capacity for diagnosis of FMD among 
the NRLs in 14 EARLN countries.2. 
Questionnaire was sent electronically to 
all labs. The areas of information 
sought- outbreaks and control 
strategies including response time, 
sampling, personnel, transportation 
issues, storage of samples, stage of PCP-
FMD, control strategies, type and 
1. 13/14 countries responded.2. All but 
one (Djibouti) experienced one 
outbreak in last five years. Outbreaks 
were reported by Vet officers in three 
countries (Uganda, Sudan, South 
Sudan). 9/13 countries outbreak were 
reported by vets and farmers. Seven 
countries from twelve submitted 
samples inconsistently to WRLFMD. 2. 
Nine countries were below PCP-FMD 
stage 3, only one at stage 3. Only 
Kenya and Tanzania used pre and post-
Limited lab capacity for FMD 
in terms of tests, equipment 
and skilled manpower 
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sources of vaccines, policies for FMD 
control 
outbreak vaccinations. Only Kenya and 
Ethiopia had vaccination plants, and 
rest imported from Botswana and 
Kenya. 4. Majority 12/13 sampling was 
done during acute phase of outbreak. 
Except Puntland all countries  
personnel were trained in FMD 
sampling. Majority reported sample 
collection between 100-1000. 5 All labs 
were able to conduct FMD diagnosis. 
The costs were US$50 per sample in 
most except Eritrea and Rwanda 
where cost for diagnosis was US$100 
per sample. Three countries used virus 
isolation (Eritrea, Kenya, Sudan), eight 
immunological detection methods, 
South Sudan also did antigen-ELISA 
and 3 used PCR. 6. None of the labs 
were accredited for FMD diagnosis but 
all except Burundi had SOPs for 
diagnosis. Only 4/13 participated in 
annual PT. Most NRL worked at BSL-2 
for biosafety except Kenya and 
Ethiopia who worked at BSL-3. Five out 
of 13 did not regularly service 
equipment and only six calibrated 
equipment annually. Except Kenya all 
reported understaffing. 
46 A systematic approach 
to capacity 
strengthening of 
1. a three stage approach was taken to 
develop assessment and monitoring 
tools for NTDs- evidence from literature 
Retrospective analysis of the tools was 
done after initial implementation and 
tools were revised. The strengths and 
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laboratory systems for 
control of neglected 
tropical diseases in 
Ghana, Kenya, Malawi 
and Sri Lanka 
on lab strengthening at individual, 
organisation, national and international 
level and generating list of components 
necessary for optimal lab system for 
NTD and using this to design a 
questionnaire based tool for lab 
managers, a semi-structure interview 
guide, capacity gap checklist and a 
checklist of ISO15189 for onsite 
observations.2. The tools were 
implemented in labs of four countries of 
CNTD/LF programme. This included 
site/institution visit with two 
complementary members from LSTM 
visiting the institutions. 62 semi 
structured interviews were conducted 
(17 Malawi, 11 Ghana, 16 Kenya, 18 Sri 
Lanka) with stakeholders. 
weaknesses in the four participating 
countries were analysed by the tools 
developed by LSTM. The categories 
included 1. people and management - 
Ghana (skills and abilities match lab 
requirements), Malawi (young and 
expanding team to support), Kenya 
(flexible lab scientist capacity), Sri 
Lanka (34 full time staff). 2. Research 
support- Ghana (research office to see 
all research activities), Malawi and 
Kenya  ( code of practice for research 
and institutional support for grant 
writing and funding, ethics 
committee), Sri Lanka (MoH ethics 
committee). 3. External interactions- 
Ghana (works with all stakeholders 
across all sectors 
locally/internationally), Malawi (offers 
of support from other labs), Kenya ( 
availability of local expertise and 
support for NTD lab development), Sri 
Lanka ( International Filariasis research 
group support). 4. Collaborations-all 
had strong links with other national 
institutions and policy makers. 5. All 
labs in four countries had the potential 
to provide support ot national and 
regional NTD control programs in 
diagnosis, vector analysis. Most 
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laboratories were seen as preferential 
collaborators. 
47 Training and service in 
Public Health, Nigeria 
Field Epidemiology and 
Laboratory training, 
2008-2014 
1. Two year course consisting of formal 
teaching and service activities. The 
competencies areas include 
epidemiology, public health 
surveillance, biostatistics and scientific 
communications as key areas with other 
optional courses. 2. Training is provided 
in four clusters of 4-6 weeks. Followed 
by exams and dissertation. Combination 
of didactic and seminar based teaching. 
3. The program has three tracks- 
medical epidemiology, veterinary 
epidemiology, lab epidemiology and 
management. 
1 Between 2008-14, 207 NFELTP 
residents were trained with 58% being 
clinicians, 26% lab scientists, 16% vets. 
595 health workers trained from short 
courses which included HIV program 
management, monitoring and 
evaluation, outbreak response and 
surveillance, vaccine preventable 
diseases, zoonoses, leadership and 
management, HIV/TB collaborations. 
The program has helped to 
address public health 
emergencies, and worked on 
the concept of one health 
bringing physicians, 
veterinarians, laboratorian 
together. Supported the scale 
up of ISDR capacity at federal 
and state level, residents help 
for analysing surveillance 
data and conducted basic 
research for program 
implementations. 
48 Critical role of 
developing national 
strategic plans as a guide 
to strengthening 
laboratory health 
systems in resource poor 
settings 
1.EHNRI established a division of 
national laboratory system to 
strengthen public health integrated lab 
system in2005. It also developed a 
national plan containing 14 strategic 
objectives that are supported by various 
institutions to implement. 2. AHPL- 
established lab quality system plan, EQA 
for HIV serology chemistry and 
haematology, lab info system with 
referral links and network of clinical labs 
with regional and national ref lab. 3. 
ASCP-involved in developing training 
curriculum in chemistry, haematology, 
CD4, preservice training curriculum for 
325 health centres providing ART 
networked with 105 testing sites. 
More than 4k DNA PCR performed at 
NRL. Development of 6 regional ref 
labs. Training in TB, malaria and other 
opportunistic infections. TB 
microscopy and smear testing 
developed. Evaluation of NSLP 
conducted 
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medical lab schools, standardisation of 
curriculum and help with setting NRL. 4. 
CLSI-technical support for developing 
and standardising lab operating 
procedures, lab layout, developing 
competency assessment tools for 
evaluating effectiveness of different  
training programs, preparing regional 
and hospital labs for accreditation. 5. 
SCMS-designing and implementing lab 
logistics management systems. 6 CU-
ICAP- support 42 labs in AIDS 
prevention, treatment and care.7. I-
TECH provides  technical assistance to 
32 hospital networks.8. CHAI helped to 
develop national quantification tools for 
lab commodities. 
49 Laboratory systems and 
services are critical in 
global health: time to 
end the neglect 
recommendations The need for developing 
comprehensive sustainable Lab 
systems is described and elements of 
lab health systems. These include-
framework for training, retaining and 
career development; infrastructure 
development, supply chain, 
maintenance of lab equipment, 
specimen referral systems, 
QC/QA/QM, lab info system, biosafety 
and waste management. This also 
include establishing PPP. Establishing 
field epidemiology and lab training 
programs; building centres of 
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excellence; Implementing affordable 
quality management and accreditation 
systems. 
50 Country leadership and 
policy are critical factors 
for implementing 
laboratory accreditation 
in developing countries. 
A study on Uganda 
A review of the National Health Policy 1, 
Health Sector Strategic Plan 2, National 
Health Lab Policy, Maputo Declaration 
on Lab services, Lab related technical 
reports of WHO. Followed by 20 key 
informant interviews- belonging to 
MoH, WHO country office, CDC office in 
Uganda, CPHL, AMREF 
1.The National Lab Technical and 
Policy Committee has the aim to 
provide leadership and coordination of 
lab services in Uganda, to develop 
national lab service policies, review 
standards and develop lab info 
management system. 2. Health sector 
strategic plan 1 and 2 focus on national 
lab network development.3 Uganda 
has active EQA in place with three 
aspects- PT, onsite evaluation, 
retesting of specimen. Currently 3 PT 
schemes exist-NEQAS PT for 
HIV/malaria/TB/OI in 250 labs. PT 
scheme for CD4 testing. The second 
involves UKNEQAS which sends whole 
blood panels from UK for testing and 
results submitted online. Third is 
regional EQA focusing on primary 
health care labs in Uganda, kenya and 
tanzania. The second EQA- onsite 
evaluation is done from CPHL with LTC 
support. THE HIVRL and National TB 
Ref lab conduct retesting and 
rechecking  as basis of EQA schemes.4.  
APHC registers private labs. 5. No 
National lab accreditation system yet 
exists in Uganda, but few (private 
A step wise accreditation is 
recommended with focus on 
specific diseases initially. 
Accreditation useful for 
standardisation and quality of 
services, compliance with 
international standards. WHO 
recommended accreditation 
should be localised for 
Uganda and setting national 
accreditation guidelines and 
standards 
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Ebenezar lab) enrolled in South African 
National Accreditation System leading 
to ISO15189 eventually. The JCRC 
enrolled for CAP accreditation. 
However the costs for accreditation 
too high to afford by most labs ($50K 
to 100K) 
51 Antimicrobial resistance: 
capacity and practices 
among clinical 
laboratories in Kenya, 
2013 
1. Retrospective reviews of lab records ( 
bacteriology records) on AST for stool 
and blood cultures were carried out to 
determine AMR patterns, and  key 
informant semi structured interviews to 
assess the lab capacity to perform  
culture and AST, practices and 
utilisation of results by clinicians.2.  
Eight public medical labs (two level6- 
national referral, four level 5-sub 
national, two level 4- district) were 
selected. The data was collected 
between Jan-Dec 2012 
1. Seven were clinical labs and one 
public health lab. 7/8 labs participating 
in WHO/AFRO stepwise lab 
improvement scheme. Only 1/8 had 
facility for Campylobacter, one had no 
records and only 3/8 performed blood 
cultures. No lab had service contracts 
for equipment and only one reported 
validation report. 7/8 lab did not 
undergo any refresher training for 
microbiological techniques.7/8 labs 
had additional biochemical tests. 4997 
stool and 4258 blood samples were 
reported. 2. AST PRACTICES-5/8 lab 
had SOP for stool sample collection, 
7/8 with culture processing SOPs, 5 
with AST SOP. Five performed internal 
QC on media and reagent and 3 
participated in external EQA (not for 
AST and culture). None had the 
capability to isolate E.Coli, although 4 
had reported organism obtained in 
them. 3. AMR PATTERN- Ampicillin and 
tetracycline resistance was shown in 
1. Inadequate capacity of 
bacterial culture and AST in 
all labs. 2. Expired cultures, 
samples and reagents were 
not regularly disposed.3. Lack 
of approved SOPs 
compromised reliability and 
accuracy of the results. Lack 
of clear guidelines in the labs 
leading to large wasting of 
resources. 
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three Shigella species isolates. 
Sulfamethoxazole resistant was seen in 
Salmonella, and also absolute 
resistance by 4 Shigella species. MDR 
was seen in E.Coli, Shigella and 
Salmonella.4. INTERVIIEWS- eight 
clinicians reported not utilising lab test 
results for patient management, the 
reason was- lack of antibiotics tested 
at labs were not available in hospital, 
delays in lab results, lack of feedback 
from lab. 
52 Strengthening 
Laboratory systems in 
resource limited settings 
The research explored three areas of 
strengthening- lab systems, 
coordination of lab efforts, adoption of 
quality standards. 1. Three data sources 
were included- Grey literature, 
interviews with major donors, site visits 
to three countries. 2. Interviews were 
conducted with 19 donor agencies and 
site visits to Ethiopia, Kenya and 
Thailand. 3 During site visits, a total of 
15 lab were visited and over 60 
interviews with host government 
personnel. 
1. Laboratory systems- The capacity 
and quality of labs rapidly dropped in 
the lower levels. Lack of equipment, 
staffing etc were common issues. In 
country brain drain from govt to 
private sector  was mentioned. 
Bureaucratic hurdles were issues with 
donor agencies. Kenya and Ethiopia lab 
system strategic plans were consistent 
with guidance documents. Fragmented 
responsibilities among different 
ministries for lab system development 
was key to lack of progress. 2. 
Coordination-Challenges for host 
systems to comply with multiple 
funding agencies at the same time. 
Donor agencies priorities revolve 
around their own mission and vision 
which can be challenging for host 
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nations. However, donor driven 
agenda can be problematic for donors 
also, in terms of need to obligate for 
longer periods, need for clear exit 
strategy, more focus on infrastructure 
development and less on leadership. 
Donor funded labs very advanced but 
not integrated with public health labs 
of the countries and hence lack direct 
operational support from the govts. 3. 
Adoption of quality systems- Countries 
with central coordination committees 
often driven by large programs such as 
PEPFAR or Global Funds are more 
successful in adopting standardised 
equipment. But equipment donations, 
small scale programs independent of 
national health strategy are challenge 
to standardisation as equipment 
donation can lead to manufacture 
monopoly, long term costs, reliance. 4. 
Thailand has comprehensive PT and 
national accreditation program (based 
on ISO 15189) but Africa focuses 
mostly on HIV testing. These rely on 
external QA programs such as UK 
(NEQAS), Canada (QASI) and Australian 
National Serology Ref Lab. 
53 Use of web based 
training for quality 
improvement between a 
The study was conducted at University 
of Chicago and IAMRAT using online 
Immunohistochemistry (IHC) training 
1. OFI (one author) received training in 
US on IHC, returned to Nigeria IAMRAT 
to set up IHC lab and provide training 
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field 
immunohistochemistry 
laboratory in Nigeria and 
its US based partner 
institution 
sessions. After initial training (stage 1), 
first performance evaluation (stage 2) 
was conducted followed by a review of 
the process and then a session of online 
training and discussion (stage 3), and 
second performance evaluation (stage 
4). 
to others, and shipping necessary 
equipment for the lab from US. 
Training in Nigeria was 12 weeks 
course including seminars, academic 
literature and hands on experience. 
Info on IHC service/lab was widely 
circulated in Nigeria. Samples of breast 
cancer tissues were referred to 
IAMRAT lab for IHC testing from 
several hospitals and stained slides 
were scored. Tissue microarray 
samples were constructed in Chicago 
with 232 tumour samples sent from 
Nigeria and IHC testing was 
performed.2. Results of the 
immunostaining were scored semi 
quantitatively by two pathologists at 
two study centres.  This was followed 
by initial concordance analysis of 
samples in Chicago and Nigeria 
(comparison). 3. The process of 
training and methods was reviews 
after concordance analysis and  web 
based conference (skype) was 
performed. Discrepancies in the 
analysis were seen in staining protocol, 
antigen retrieval procedures, scoring 
methods. Following this a joint 
evaluation of digital slides was 
conducted addressing technical issues. 
4. Second evaluation of 
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immunostaining was conducted and 
assessed in Chicago. The concordance 
between Nigeria slides and Chicago  
slides was seen to have improved.   
54 Strategy for 
strengthening scientific 
capacity in developing 
countries on water and 
sanitation related issues 
The strategy is built on four 
cornerstones 1.-providing means to 
researchers to attract funds to initiate 
new project: through training, and 
support, review of proposals by 10 
international experts, workshops on 
revision of projects and follow up 
guidance and support from local 
organisations. 2. Facilitations in 
generating high quality results: training 
in research methods, site visits to GLP 
labs, support in equipment 
procurement, mobilising networks. 3. 
Dissemination and implementation of 
results: training in presentation 
techniques (oral/poster), mentorship, 
funds for publication costs, local 
dissemination workshop support. 4. 
Follow up on implementations: 
workshops and follow up grants on 
competitive terms. 
IFS grantees and resource persons 
participate in training of the trainers 
who later disseminate program. A 
close contact with end-users is 
encouraged who are also participants 
in research (action research). New 
researchers are targeted with focus on 
gender balance, type of research 
topics. Continuous monitoring and 
evaluation is conducted in different 
phases; from initiation of new projects, 
access to equipment, key focal points 
at local level. 
 
55 Improvement of 
Tuberculosis Laboratory 
capacity on Pemba 
island, Zanzibar: a health 
cooperation project 
The infrastructure development was 
done in four different phases. Phase 1-
identification of suitable space, 
checking of useful material, designing 
lay based on WHO standards, testing of 
biosafety level 2 cabinet with 
Between 2007-2010 921 samples were 
sent to TB section of PHL-IdC from 14 
peripheral labs in Pemba and since July 
2009 26 peripheral labs in Unguja 
island. 121 pulmonary TB cases were 
diagnosed. From 115 smear positive 
 
A low cost  intermediate lab 
set up within a short space of 
time. However, need to 
maintain supply of reagents, 
focus on transportation of 
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centrifuge, micro centrifuge, incubator. 
Phase 2- Lab equipped with light 
microscope, incubator, combined fridge 
and orbital shaker. Reagents and 
disposables for smear microscopy. 
Phase 3-Training of lab personnel in 
smear microscopy and solid culture on 
LJ media. Phase 4.- HR capacity building 
reinforcement by teaching training, 
monitoring and mentoring by internet. 
The diagnostic methods included smear 
preparation using ZN methods. The 
Internal quality assurance system was 
established but no EQA.   
cases, 84 were culture positive, and by 
2010 the smear positive to culture 
positive rates reached 100%. 
samples, are important for 
optimal services. 
56 Improvement of 
Tuberculosis Laboratory 
capacity on Pemba 
island, Zanzibar: a health 
cooperation project 
The infrastructure development was 
done in four different phases. Phase 1-
identification of suitable space, 
checking of useful material, designing 
lay based on WHO standards, testing of 
biosafety level 2 cabinet with 
centrifuge, micro centrifuge, incubator. 
Phase 2- Lab equipped with light 
microscope, incubator, combined fridge 
and orbital shaker. Reagents and 
disposables for smear microscopy. 
Phase 3-Training of lab personnel in 
smear microscopy and solid culture on 
LJ media. Phase 4.- HR capacity building 
reinforcement by teaching training, 
monitoring and mentoring by internet. 
The diagnostic methods included smear 
Between 2007-2010 921 samples were 
sent to TB section of PHL-IdC from 14 
peripheral labs in Pemba and since July 
2009 26 peripheral labs in Unguja 
island. 121 pulmonary TB cases were 
diagnosed. From 115 smear positive 
cases, 84 were culture positive, and by 
2010 the smear positive to culture 
positive rates reached 100%. 
A low cost intermediate lab 
set up within a short space of 
time. However, need to 
maintain supply of reagents, 
focus on transportation of 
samples, are important for 
optimal services. 
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preparation using ZN methods. The 
Internal quality assurance system was 
established but no EQA.   
57 Experience establishing 
tuberculosis laboratory 
capacity in developing 
country context 
FIND team conducted a needs 
assessment of NTRL and developed a 
multi-phase work plan for upgrade. 
Phase 1- developing training modules 
and manuals followed by upgrading 
training in sputum microscopy and 
refresher training in smear microscopy. 
QA program was established based on 
online evaluation, supervision and blind 
checking, LQAS sampling was put in 
place for EQA of smear microscopy 
across all health centres.  Regular Panel 
testing carried out from samples 
obtained  SNRL South Africa for EQA. 
Phase 2- NTRL renovated with BSL3  
facility to meet WHO standards for 
handling  liquid TB culture, TB solid 
culture and DST implemented with EQA 
provided by SNRL in South Africa.  TB 
liquid culture, DST, rapid immunoassay 
based species identification,  LJ media 
for isolation from solid culture, BACTEC-
MGIT 960 TB system for liquid culture 
were introduced.  Phase 3-activities to 
prepare for introduction of the LPA for 
detection of MDRTB began with 
construction of a clean room facility, 
1. The TB diagnostic capacity increased 
from less than 100 to more than 700 
culture per month by June 2008. 2. The 
validation of liquid culture method in 
Dec 2008 revealed the contamination 
rates  1.9% for solid and 7.8% for liquid 
cultures. There was 14% increase in 
the sensitivity of liquid culture 
compared to solid culture by 
immunochromatographic assay. 
Between Jan'08 and Mar'09, 8569 
specimen were cultured including the 
use of LJ and MGIT with an overall 
contamination rate of 10.8%, with 87% 
culture positive.2 After validation and 
retraining  LPA has started to be 
routinely used. 3Microscopic 
examination for smears increased from 
900 to 85471 per month at 14 
different microscopic centres and 
NTRL. Of these 33473 slides/14372 
patients were examined at NTRL. 
A high profile project 
attracted lot of attention and 
requests for training from 
other African countries, 
which could be stressful for 
the staff, and add to the 
workload who could miss out 
on different training 
opportunities. 
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followed by introduction of the assya 
and training of the lab staff. 
58 Capacity building in 
response to pandemic 
influenza threats: Lao 
PDR case study 
1. GoL established a coordination entity 
in 2006- National Avian and Human 
Influenza Coordinating office (NAHICO) 
directly under PM office in 2006, which 
was later expanded in 2009 as National 
Emerging Infectious Disease 
Coordinating Office (NEIDCO) in May 
2009. 2. NCLE held forum/meeting with 
WHO and USCDC to develop a road map 
for NIC designation. USCDC and Pasteur  
provided training, oversight and helped 
to set QA standards to develop new 
strategies at NCLE for public health 
laboratory detection process. This 
included  starting up PCR testing and 
training to local lab personnel 
(coinciding with H5N1 outbreak), 
participating in WHO EQA and with this 
contributing to WHOGISRS and WHO 
FLUNET. 2. Establishment of virological 
sentinel surveillance network to 
combine respiratory illness with 
pandemic and seasonal influenza 
(EWARN). 3. Field Epidemiology Training 
(FET) initiative to  develop technical 
cadre of public health professions 
networked throughout the country.4 
Use of Real-time PCR to improve testing 
capacity.   
1. till 2011 294 influenza samples and 
viral isolates submitted to WHO GISRS. 
EQAP competence ratings 90-100% for 
PCR, 80-100% for rPCR. Single 
molecular sequencing platform for 
both human and animal health 
laboratories (one health approach). 2. 
EWARN expanded from 33 to 144 
districts in all 17 provinces. 3.Rapid 
recognition and response to outbreak 
due to timely verification and follow 
up of cases to identify human clusters 
through training of the trainer 
approaches and decentralisation of 
reporting mechanisms. 3. Rapid 
recognition in outbreak and response 
time taken, decentralisation of 
outbreak reporting. 23 FET trained 
personnel to conduct outbreak 
investigations, pandemic containment, 
mitigation, adverse effects of 
immunisations, expansion of SARI and 
ILI surveillance. Expansion of the 
network to include other epidemics 
and outbreaks, for example Japanese 
encephalitis, human anthrax, dengue, 
cholera etc. 
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59 Medical laboratory 
quality and accreditation 
in Jordan 
narrative 1. MoH responsible for running all 190 
labs, distributed at peripheral, 
intermediate and central levels. Also 
Military medical services run 8, 
university hospitals 2, UNRWA 24, 
Charity based 15, Private sector 351. 
Licencing of the labs is mandatory by 
law, MoH has set up standards for 
quality control and assurance and by 
law all labs need internal QA and 
participate in EQA if existing. Focus on 
QC in training programs and last 10 
years National External Quality 
Assessment Schemes were 
implemented in bacteriology, virology, 
parasitology and clinical chemistry. 2 
Accreditation- new concept in Jordan 
and there are no regulations at present 
for accreditation. Few labs have 
ISO9001:2000 and USO 15189:2007. 
Jordan Institute of Standards and 
Metrology (JISM) has specialised unit 
in accreditation (JAS) which is 
developing. Healthcare Accreditation 
subcommittee is constituted and 
tasked with planning of Jordan Health 
care Accreditation and Certification 
Commission (JHACC) which is 
responsible for accreditation and 
certification, and developed first draft 
of accreditation for hospitals.  This 
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draft implemented in 17 hospitals- 8 
public, 5 private, 2 military, 2 
university. 
60 Role of Laboratories and 
Laboratory systems in 
effective tuberculosis 
programmes 
narrative Need for drug susceptibility testing is 
emphasised in light of resistance. EQA 
programmes should focus on how 
smears are performed and interpreted. 
Given that LMICs do not have basic 
capacity for  drug resistance 
surveillance (DRS) or MDRTB, 
appropriate use of current limited 
culture capacity should be encouraged. 
Use of NAAT for rifampin resistance is 
recommended, however with 
achieving robustness of the results. 
'On the job' training for AFB 
microscopy and HIV rapid testing is 
encouraged for improving lab 
personnel capacity. TB cases reporting 
should be made mandatory and 
national TB programs and NRLs should 
ensure EQA for private labs. An 
integrated NRL is preferred than stand 
alone ref lab specific for TB. 
Microscopy labs in LMICs can invest in 
low cost fanboxes, relatively 
inexpensive than expensive biosafety 
cabinets. If suitably installed these 
provide similar level of protection. 
EQAs are expensive, an effective way 
of supranational EQA is through 
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mentorship of NRLs and exchange of 
strains between them to measure 
performances. Research is encouraged 
to be performed in the field labs in 
LMICs than established academic 
institutions , and helps to improve the 
capacity of operational field research. 
61 Certification of TB 
culture and drug 
susceptibility testing 
laboratories through the 
revised National TB 
control programme 
(RNTCP) 
narrative A formal application is made to the 
CTD for accreditation for C&DST (stds 
based on ISO15189), which after 
scrutinising forwards to NRL for further 
processing. The steps for accreditation 
involve- a pre-assessment visit by team 
of NRL for reviewing infrastructure 
facilities, C&DST equipment, qualified 
and trained personnel, SOP, technical 
procedures, workload capacity, 
biosafety and infection control 
measures. Based on initial assessment, 
customised recommendations are 
made. 2. Once labs comply with 
recommendations, labs are assessed 
for performance based on first 100 
patient samples for culture and DST for 
contamination and proficiency for 
setting up interpretable DST tests. 3. 
NRLs provide external blinded 
proficiency testing for 20 panels for 
susceptibility testing for anti-TB drugs 
for assessment of accuracy in 
sensitivity, specificity, positive and 
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negative predictive value and 
certification is if >90% results are 
achieved. The overall time taken for 
the process is 6-7 months. The 
program is encouraging other labs, 
such as ICMR labs, medical colleges 
labs, private labs for C&DST 
accreditation. 
62 Capacity building efforts 
by the AFHSC-GEIS 
program 
The AFHSC- GEIS sponsored activities 
involved renovation existing labs, 
furnishing new scientific equipment, 
provision of new or enhanced 
diagnostic testing equipment, at 
overseas DoD facilities and US based 
influenza centres, which served as 
regional reference labs and host 
country labs. Over 80 MoHs, Agriculture 
and defence and other institutions in 74 
countries were involved, including 52 
National Influenza Centres, EID ref labs 
were supported in this program. Focus 
was on human health entities. Also 
involved development of two new BSL-3 
labs in Thailand (AFRIMS and NHRC) 
providing WHO and South East Asia 
regional support in research and assist 
with outbreaks. Two BSL-2 labs were 
established in Cameroon to target 
Africa. 2. To support Influenza 
surveillance AFRIMS established 
viral/bacterial pathogen culture and 
1 Capacity building initiatives by 
geographic regions. South East Asia 
(Bhutan, Cambodia, Lao, Nepal, 
Singapore, Thailand)- NIC and Military 
influenza lab equipment, reagent and 
training, EID lab diagnostics and 
disease surveillance system. Far East 
(Japan, Korea, Philippines)-NIC and 
Military influenza lab equipment, 
reagent and training, EID lab 
proficiency and equipment. East and 
Central Africa (Cameroon, Kenya, 
Tanzania, Uganda)- NIC & VHF lab 
equipment, reagent training and 
support, EID lab diagnostics. West 
Africa (Benin, Burkina Faso, Cote 
D'lvoire, Ghana, Liberia, Mali, Niger, 
Sierra Leone, Togo)- NIC & MoH 
influenza lab equipment, reagent and 
training support, VHF lab diagnostics 
and military EID lab diagnostic testing 
capacity. North Africa, Middle East and 
South West Asia (Afghanistan, Egypt , 
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molecular diagnostic capacity in Nepal 
equipped with rPCR for diagnosis. 
NAMRU-3 also established influenza 
Centres in Afghanistan, Iraq, Jordan and 
NMRCD in Columbia, Ecuador, 
Paraguay, Venezuela, and US-Army 
Medical Research Unit in Kenya. 
USPHCR South supported El Salvador, 
Guatemala, Honduras, Nicaragua and 
Panama. 3. Training-  in 2009 AFHSC-
GEIS supported 18 organisations to 
conduct 123 training initiatives in 40 
countries with 3130 people trained  to 
assist work compliant with IHR 
regulations. 
Iraq, Jordan, Kuwait, Oman, Pakistan, 
Syria, Sudan)- NIC lab equipment, 
reagent and training support. Central 
Asia (Azerbaijan, Georgia, Mongolia)- 
EID and influenza lan equipment, 
reagent and training support. Europe 
(Poland, Romania)- Military and 
academic influenza lab equipment, 
reagent and training support. Central 
and South America (Colombia, 
Ecuador, El Salvador, Guatemala, 
Honduras, Nicaragua, Panama, 
Paraguay, Peru)- NIC&MOH influenza 
lab equipment, reagent and training 
support, leishmania military reference 
lab equipment, reagent and training 
support. 
63 Capacity building for 
zoonotic and foodborne 
diseases in the 
Mediterranean and 
Middle East Regions (an 
intersectoral 
WHO/MZCP proposed 
strategy) 
Based on WHO's one world one health 
concept, Mediterranean Zoonosis 
Control Program (MZCP) is proposed, 
based on multi-disciplinary and multi 
sectoral collaboration and coordination 
as a core tool for preparedness to 
address global impact of endemic 
zoonotic and food borne diseases with 
particular emphasis on emerging and 
re-emerging conditions. 2. It involves 
knowledge sharing, promoting 
technologies, horizontal 
communication, public health training 
The MZCP focuses on building robust 
public health and animal health system 
compliant with IHR and OIE standards. 
Activities include- mized training 
groups of physicians, veterinarians, 
biologists, health and food inspectors, 
lab staff and other personnel. 2. 
Intercountry and national training 
courses on epidemiological 
surveillance of zoonoses and food 
borne diseases; food safety and HACCP 
systems and food security; 
environment and public health; 
seminars on intersectoral collaboration 
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program and motivating community 
participation 
and coordination in zoonotic and 
foodborne diseases and other relevant 
areas of interest. 
64 Scale up of MDRTB 
laboratory services, Peru 
Between 1996-2000, PARTNERS 
consortium was established with help of 
US$ 45 million from Gates Foundation 
to achieve national coverage of MDRTB 
and replicate it at other places.2. 
Decentralisation of Rapid DST in 7 
regional labs in order to obtain timely 
results. 3. Use of first line DST in 
regional labs and Second line DST at INS 
for high risk patients. Prior to that an 
assessment was carried out in two 
district hospitals for efficiency, biosafety 
facilities, needs of personnel training for 
the possibility of decentralisation. 4. 
The preparation phase-mobilising 
political commitment, infrastructure 
development, workforce development 
through Biosafety cabinet (BSC) training 
and certification. This involved inviting 
applications to become regional labs for 
DST and supporting two for renovations 
to see challenges in the process. In 
parallel, Training and validation for each 
DST method. 5. Implementation phase- 
DST incorporated into program services. 
Monthly review of aggregate data for 
contamination rates, culture growth, 
drug resistance with supervisory visits 
1.  Between 1996-2006 the number of 
DST performed and mycobacterial 
cultures doubled.2. The monitoring 
phase showed that health personnel 
often failed to adhere to NTP norms 
for DST.  Approx 50% of the DSTs in 
2005 were for patients without an 
indication for DST, 28% of those were 
for patients with MDRTB, although 
there was an increase in demand for 
DST because of awareness of MDRTB 
and benefit of rapid real-time testing. 
Responding in time and 
stepwise overlapping efforts 
to prevent delays- stepwise 
decentralisation and 
dedication to human 
resources. Coordination of 
NRL and NTBP with stable 
political leadership. Within 
DOTS model smear 
microscopy can be performed 
at health centres with local 
coordination with TB 
services. Operational 
research is important for 
understanding research and 
program conditions. 
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from INS staff to regional labs, and also 
to provide training. 5. Monitoring 
phase- long term evaluation of 
reinforcement of NTP norms, 
appropriate use of DSTs and culture 
data, DST indicators and optimal DST 
methods should respond to changes in 
regional epidemiology as well as 
availability of resources. 
65 ASM LabCap's 
contributions to disease 
surveillance and 
International health 
regulations (2005) 
LabCap contributes to several 
programs. 1. LabCap- PEPFAR initiative- 
capacity building of global HIV and 
clinical microbiology laboratories in 
resource constrained countries. This 
also includes diagnostic capacity 
strengthening in HIV/AIDS related OIs, 
TB through technical assistance and 
mentoring onsite, needs assessment, 
development of QA/QC. SOPs and 
establishment of NRLs/NPHLs, referral 
networks, surveillance and outbreak 
response, optimisation of lab policies, 
assisting in accreditation and 
certification. 2. ASMLabCap- CDC 
training: two international courses on 
AFB smear microscopy EQA, MtB 
culture, DST, microbiology workshops. 3 
IEIP initiatives: technical expertise and 
consultation in lab capacity building for 
clinical microbiology for respiratory 
condition and implementing active 
1. ASM-PEPFAR: in Botswana, Cote 
d'Ivoire, Ethiopia, Guyana, Haiti, 
Kenya, Mozambique, Namibia, Nigeria, 
Rwanda, Tanzania, Vietnam, Zambia, 
DRC, Central Asian Republics, Ukraine. 
2 LabCap-CDC training: Smear 
microscopy EQA Tanzania 
(participation from other English 
speaking countries in Africa), Senegal 
(other French speaking countries)l; DST 
in Cote d'Ivoire; microbiology 
workshops in Botswana, Kenya, 
Mozambique, Tanzania, Zambia; 
national workshop on enteric disease 
surveillance and response in Kenya. 3. 
IEIP initiatives: China ( PCR and non-
PCR based evaluation and write SOPs), 
Guatemala (review blood culture 
processing and give recommendations; 
including using susceptibility testing 
via disk diffusion), Thailand ( 
evaluation of sample collection 
Enables indegenious lab to 
more rapidly and effectively 
identify and respond to broad 
range of diseases, 
transferring QA skills 
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surveillance for pneumonia. 4. ASM-
PATH India: strengthening  Intermediate 
Ref Lab (IRL) network to perform Mtb 
culture and DST and obtain national 
accreditation. 5. TB IQC with PATH 
USAID: providing extensive support to 
USAID operating units in the 
implementation of their TB programs 
through introduction and expansion of  
components of WHO recommended 
STOP TB strategy. 
 
 
procedures, transport, processing and 
identification). 4. ASM-PATH India: 
evaluation of 8 states using IRL 
assessment tool, guidelines for 
preventative measures and biosafety 
manuals, recommendations for 
workshop. 5. IQC partnership: 
partnership through consortium of 
FIND, Partners in Health, MSH, UCSF, 
Brigham and Women's hospital to 
expand WHO STOP TB strategy. 
66 The WHO/PEPFAR 
collaboration to prepare 
an Operations Manual 
for HIV prevention, Care 
and Treatment at 
Primary health Centres 
in High prevalence, 
resource constrained 
settings 
narrative 
 
 
The operations manual describes 
principles, planning for integrated HIV 
services at PHC, services linkages 
integration triage, infrastructure, 
monitoring patients and programs, 
supply management, lab services, 
human resources, leadership and 
management, quality improvement. 
The tests needed by PHC include: rapid 
HIV antibody test with counselling, 
Rapid Syphilis test, malaria test, for 
infant diagnosis DBS and send out for 
virologic testing, Hb and haematocrit 
determination, urine dipstick for sugar 
and protein, rapid pregnancy test, 
malaria smear testing, TB smear 
microscopy, blood sample collection 
for CD4 and full blood count. At district 
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level, additional tests such as AFB 
smear microscopy, Syphilis RPR, gram 
stains etc should be available. The 
supplies include: log books for HIV, STI, 
syphilis, DBS. TB sputum smear 
microscopy request form, TB registry 
book, Infant PCR lab requisition form 
with program monitoring data, CD4 
request form, pregnancy test 
worksheet. 
67 POPs analysis reveals 
issues in bringing 
laboratories in 
developing countries to 
a higher quality level 
1. Initial needs assessment 
(questionnaire and interviews) was 
carried out in 18 labs on infrastructure, 
equipment, consumables, staff etc. 
Following which customised on site 
training was organised for each 18 labs 
for two weeks on POP analysis, QA/QC 
procedures and hands on lab training. 2 
After training performance of all labs 
were assessed by inter-laboratory study 
on dioxins (di), polychlorinated 
biphenyls (PCBs), non-di (ndl) PCBs, 
organochlorine pesticides. In addition 
labs also provided samples they 
analysed to the expert lab (mirror 
analysis). 3 The results of this 
performance were evaluated in a series 
of workshops organised in different 
regions with focus on transfer of 
knowledge and discussion on challenges 
and successes. 
1. Lab infrastructure and environment- 
Lack of appropriate infrastructure 
(roads/lab windows/ appropriate lab 
temp) in Africa  is detrimental for trace 
analysis with loss of compounds with 
low boiling point and mass 
spectrometry. Fume hood capacity 
limited exposing technicians to 
chemicals and occupational health risk. 
Records of consumables, reagents not 
maintained. 2. Procurement of lab 
consumables and instrument 
maintenance- lack of consumables and 
lengthy ordering procedures leading to 
delays or stopping analysis. Use of 
alternatives and creativity to maintain 
lab at minimum level was seen ( 
replacing rotary evaporator with 
removing Soxhlet cooler but 
maintaining warming mantle for 
example). 3. Training and building up 
Need for more inter-
laboratory assessments of 
ionic PFAS in fish, food, 
water, sediment, human 
milk, 
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expertise and routine- lab expertise 
varied between different regions. Asia 
and South America the expertise were 
higher than Africa with knowledge on 
lab management and POP analysis. All 
labs received two weeks training on 
POP analysis, hands on onsite training 
in the labs but this was not sufficient 
to come to required standards, for 
which 6 months are needed for PCB 
and OCP analysis. Increasing frequency 
of POP analysis would help in training. 
4. QC/QA-  quality control and 
assurance particular bad in South 
America and Africa and most labs were 
not accredited to ISO standards, 
performance criteria for methods and 
validation of studies were not set. 
68 Laboratory capacity 
building in Asia for 
infectious diseases 
research: experiences 
from the South East Asia 
Infectious Disease 
Clinical Research 
Network (SEAICRN) 
1. One SEAICRN lab was established at 
Mahidol University, Thailand and 
reference labs for different aspects of 
research in the countries in order to 
carry out influenza and other infectious 
diseases related 32 RCT in these 
countries at international standards 
levels using RT-PCR. All 15 labs in 4 
countries were developed to MDL level. 
2. BSL-3 facility was established in 
Hospital for Tropical Diseases, Vietnam 
for isolation of H5N1 viruses and 
emerging pandemic influenza viruses, 
1. Thailand- 5 labs, Vietnam 5 lab, 
Singapore 1, Indonesia 4 labs were 
established. 2. All labs also use MDL 
for other activities such as HIV, 
Hepatitis, Meningitis, dengue, 
encephalitis.3. Training courses: PhD (6 
scientists enrolled), Masters (9) and 
295 short term fellowships provided. 
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along with pyrosequencing facility to 
detect mutations and drug resistance.3. 
Onsite training was provided at all labs 
for real-time RT-PCR, molecular 
diagnostics and contamination 
prevention.4 All labs were enrolled in 
two different EQA programs and PT was 
performed for all sites before patient 
screening was allowed.5 Staff was given 
specific training for conducting RCTs 
and a centralised specimen labelling 
and database system was established 
for all SEAICRN trials.5. Clinical 
Laboratory quality improvement 
program was also initiated, involving 
assessment of each hospital clinical lab 
against international standards, 
equipment maintenance and 
calibration, enrolment in EQA, 
assessment of training needs, review of 
ref values used, accreditation status. 
follow up was done through training, 
recommendations, developing SOPs, 
and document control systems, 
appointment of Quality officer in all 
hospitals. 
69 The role of standards 
and training in preparing 
for accreditation 
WHO-CDC-CLSI training toolkit has been 
developed to support trainers which 
can be localised and customised for 
national and local needs. For example: 
five major zonal labs in Tanzania have 
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Recommendations 
been supported to develop quality 
management systems. Done through 
onsite mentoring and series of 
workshops. Similar efforts in Ethiopia, 
Cote d'Ivoire 
70 Improving quality 
management systems of 
laboratories in 
developing countries 
1. An assessment checklist was 
designed to quantitatively define the 
situation in the lab in terms of 
observable measurable results. It can be 
used for supervisory visits, planning and 
evaluating lab improvement projects, 
and assessing training and effectiveness 
of SLMTA. It was subsequently adopted 
as WHO-AFRO checklist for lab 
accreditation. This checklist was field 
tested in Ethiopia and Uganda by 
interviewing 22 lab managers from all 
the four levels (national, 
regional/provincial/district/community). 
The 10 modules in the toolkit for 
assessment resemble the key areas of 
SLMTA framework. The toolkit contains 
keys areas of work, desired outcomes 
and tasks that managers need to 
perform. 3. The pilot included series of 
3 workshops conducted by CDC ASCP 
facilitators with 3-4 months gap. 
The goal of pilot testing was to assess 
the efficacy of SLMTA program, 
specifically task based approach and 
multi workshop delivery model, 
capturing lessons learnt, refining 
curriculum. Sample improvements 
were seen in Kawolo hospital Mukano 
in terms of organising store room, 
Nkozi hospital Mpigi with regards to 
improving data collection, STI clinic 
Mulago in terms of implementing duty 
roster. 
 
71 The SLMTA programme: 
transforming the 
laboratory landscape in 
developing countries 
1. SLMTA curriculum covers 10 key 
competencies of a lab manager- 
productivity, work area, inventory, 
procurement, equipment maintenance, 
Some examples from SLMTA include 1. 
Cameroon- used facility based 
decentralised model for training 
instead of one centralised program 
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QA, specimens, lab testing, test results 
reporting, documents and record 
control. Total of 66 tasks define 
effective lab management and 
constitute objectives of SLMTA 
curriculum.2. SLMTA runs between 12-
18 months involving a series of 3-4 day 
workshops utilising 44 instructional 
activities and more than 100 job aids. 
Each activity is hands on, practice based 
learning experience for specific 
management tasks.3. Post training two 
types of improvement projects are 
implemented-complicated projects 
requiring data collection before and 
after implementation and simpler 'just 
do it' type that can be implemented 
straightaway. This is supported by 
periodic supervisory visits or on-site 
mentoring guided by standardised 
tools.4. This is followed by formal lab 
evaluation component for accreditation 
under WHO-AFRO SLIPTA programme 
which is 5 stage preparedness scheme 
that recognises labs according to their 
compliance with ISO 15189 standard. 5. 
SLMTA can be organised and adapted to 
local environments 
due to lack of resources. Lesotho- the 
schedule and frequency of training 
adapted to match existing mentorship 
timetables. Mozambique- SLMTA 
integrated in existing structure of MoH 
lab system. Rwanda- adoption of data 
driven advocacy by tracking number of 
tests not performed, funds required, 
and prospective revenue that can be 
generated. Cameroon-after initial 
SLMTA one hospital devised its won 
quality improvement teams for other 
units in the hospital.  Zimbabwe- 
extensive resource challenges were 
met by manually writing and paper 
based system where computers were 
not available. 2. SLMTA adopted 
training of the trainers approach was 
scaling up. A teach back of assigned 
activities is conducted for receiving 
constructive feedbacks. 3. For SLMTA 
to run- a national lab policy and plan, a 
technical working group is pre-
requisite, equally crucial is appropriate 
site selection with advise on small start 
and then scaling up. SLMTA requires 
three types of cadres- trainers to teach 
curriculum, auditors to perform 
internal audit, and mentors to 
facilitate projects. 4. Globally- outside 
Africa 24 more countries from 
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Caribbean, Central and South America,  
and South East Asia have adopted 
SLMTA. 
72 Field experience in 
implementing ISO 15189 
in Kimisu, Kenya 
The journey towards accreditation 
involved 1. The lab conducted 
consultation (outsource) with Contract 
Lab Services who identified ISO 15189 
as appropriate international 
accreditation. It conducted gap analysis 
in QMS and advised on implementing 
ISO standards. Lab constituted 
independent Quality System Unit (QSU) 
to evaluate areas of improvement 
based on Contract Lab Services 
assessment. QSU developed various 
documents and systems- lab quality 
manual, quality policies, SOPs, staff 
competency assessment guidelines, 
complaint/incidence reporting systems, 
quality indicator systems, internal QA 
auditing system, documents and 
records control system. 2. Enrolment 
for EQA  with CAP, Virology Quality 
Assurance Program, UKNQAS, Humane 
Quality Assurance Services. 3. 
Infrastructure and information systems 
were developed such as automated 
temperature monitoring and 
streamlining sample reception, 
repository and tracking. 4. Initial 
Assessment done by US PPD prior to ISO 
1. Challenges in achieving ISO 15189: 
expensive and labour intensive, lack of 
trained personnel in QMS for GCLP, 
lack of professional in country trainers, 
equipment procurement from abroad, 
implementing safety standards. 2. Post 
achievement challenges- staff 
retention and move to other labs,, 
maintaining reliable supply of 
commodities at manageable costs, 
increased workload and client 
demands,, continuous  nurturing of 
'culture of quality'. 3. Essential 
elements of managing accredited lab 
involve- well organised lab 
management system, strengthening of 
QSU which improved QA standards, 
establishing a lab technical advisory 
committee, establishing and 
monitoring lab quality indicators based 
on 7 areas of assessment ( Quality 
management, resource utilisation and 
financial performance, process 
efficiency and effectiveness, risk 
management and safety, client 
satisfaction, personnel performance 
and satisfaction, data management), 
1. Creation of reliable and 
competent workforce, 
greater internal control and 
good tracking system, reliable 
infrastructure for tracing 
errors and complaints. 2. 
Timely identification of 
weaknesses and rapid 
resolution leading to 
reductions in operation costs 
and time savings.3. Accurate, 
reliable, quality and timely 
service delivery, reduction in 
sample rejection 
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assessment by SANAS to address the 
existing gaps. Followed by ISO 15189 
accreditation. 
promoting continuous quality 
improvement. 
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Annex 4: Quality system elements of ISO15189 accreditation 
 
List taken from Young (2010)(75) 
 
1. Organisation and management  
2. Quality management system 
3. Document control 
4. Review of contracts 
5. Examination by referral laboratories 
6. External services and supplies 
7. Advisory services 
8. Resolution of complaints  
9. Identification and control of non-conformities  
10. Corrective action 
11. Preventive action  
12. Continual Improvement  
13. Quality and technical records 
14. Internal Audits 
15. Management review 
16. Personnel  
17. Accommodation and environmental conditions 
18. Laboratory equipment 
19. Pre-examination (pre-analytical) procedures 
20. Examination (analytical) procedures 
21. Assuring quality of examination procedures 
22. Post-examination (post-analytical) procedures 
23. Reporting of results  
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Annex 5:  Stepwise Laboratory Improvement Process Towards Accreditation 
 
The primary focus of the SLIPTA is to improve laboratory Quality Management Systems 
(QMS) to prepare laboratories for accreditation to ISO15189. This is the international quality 
management standard specific to medical laboratories used in most high-income countries, 
including the National Health Service. The ISO 15189 standard is designed to ensure the 
accuracy and suitability of results produced by the laboratory.  Though initially focused on 
TB and HIV the SLIPTA tool is generalizable and could be modified to address AMR 
laboratory surveillance capacity.  
 
Description of tool 
Engagement of stakeholders 
 
The WHO regional office initially coordinates the establishment of Memorandums of 
Understanding (MOUs) with Ministries of Health and facilitates the establishment of regional 
Independent Evaluation Groups (IEGs).  The IEG is the primary vehicle of engagement with 
governments. MoHs can only be supported through the SLIPTA process if they apply which 
demonstrates some degree of buy in to the process from the MoH. It is down to the MoH to 
select the laboratories for enrolment in SLIPTA. 
 
Laboratory audit 
 
Once enrolled a team of auditors will be sent to audit the countries selected laboratories 
within a year. The laboratories are audited using the following criteria: 
 
1. Laboratory test results; 
2. Number of tests annually: defined as total annual volume of tests performed by 
laboratory; 
3. Internal quality control procedures implemented for all testing methods used; 
4. Two most recent proficiency test results for each test performed; 
5. WHO SLIPTA Checklist for the African Region. 
 
The SLIPTA checklist audits the laboratory using the twelve laboratory quality system 
elements (QSE) to produce an overall score (table A5.1) 
 
Table A5.1: Scoring of 12 QSE  
 
Section QSE Points available  
1 Documents and Records 28 
2 Management Reviews 14 
3 Organization and Personnel 22 
4 Client Management and Customer Service 10 
5 Equipment 35 
6 Internal Audit 15 
7 Purchasing and Inventory 24 
8 Process Control and Internal and External Quality 
Assessment 
32 
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9 Information Management 21 
10 Corrective Action 19 
11 Occurrence Management and Process Improvement 12 
12 Facilities and Safety 43 
 Total  275 
 
 
Following the audit a list of errors (non-conformities) are presented to the laboratory and six 
weeks are given to allow the laboratory to present evidence that the non-conformities have 
been addressed. For serious non-conformities a follow up audit may be required.  The 
laboratory will then be rescored and a star rating given and a certificate of recognition 
issued, valid for 2 years. This certificate does not equate to any type of accreditation.  
 
Table A5.2: SLIPTA star grading 
 
Grade 0 star 1 star 2 star 3 star 4 star 5 star 
Score 0-150 151-177 178-205 206-232 233-260 261-275 
 
